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Abstract 
This thesis describes the NMR-guided isolation and structural elucidation of one novel 
and several known compounds from marine organisms collected from Tonga and New 
Zealand.  In the process of this work, 11 Tongan algal specimens were subjected to 
preliminary NMR-guided investigation, as the study of Tongan marine algae is poorly 
represented.  The HMBC spectra of crude fractions generated by the first 
chromatographic purification of the crude extracts were analysed for perceived 
structural novelty, providing three specimens that warranted further investigation. 
Investigation of unknown algae PTN4_17G afforded substructure 76, observed in the 
known compound avrainvilloside, which included the rare 6-deoxy-6-aminoglucose 
moiety.  This aminoglucose moiety has been reported from marine sources only twice 
in literature, both in algae specimens.  An investigation of unknown brown algae 
PTN4_18E afforded substructure 83, a methacrylic acid containing moiety.  Methacrylic 
acid moieties are also uncommon in marine organisms, with 27 reported structures 
containing the moiety, of which only two occur from algae.  In each case suitable, mass 
spectrometry data was not obtainable therefore full structural elucidation of the 
compounds was not achieved.  Further analysis of the unknown algae PTN3_38C 
afforded the known compound fistularin-3 86, although further studies revealed that a 
sponge contaminant was responsible for the presence of the compound.  The results 
of this algae study provided interesting correlations between secondary metabolite 
concentrations of algae in temperate and sub-tropical environments, contrary to the 
observed correlations of marine sponges.  
An investigation into an unknown New Zealand Raspailia sponge was conducted as 
previous studies had suggested the presence of novel resonances.  Further analysis of 
the specimen yielded the known clerodane raspailodane A 126 and the unexpected 
novel steroidal glycoside raspailoside A 135.  Biological activity studies conducted on 
raspailoside A showed inactivity towards the mammalian cell line HL-60 and 
Saccharomyces cerevisiae assays. 
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Chapter 1  
 
Introduction 
1.1. The Role of Natural Products in Traditional Medicine 
Throughout the ages the natural environment, whether it be on-land or in the oceans, 
has provided human civilisations with resources for the production of foodstuffs, 
shelters, clothing and means of transport.1  History has also shown us how the use of 
terrestrial plants formed the basis for traditional medicines and herbal remedies with 
the earliest records dating back to 2600 BC, in Mesopotamia.2  Further evidence has 
been observed in records throughout history documenting the use of plants in 
traditional medicine systems.1-2  Biologically active secondary metabolites, present 
within the plant material, are considered to provide the therapeutic effect that these 
traditional medicines possessed.  These secondary metabolites are naturally produced 
chemical substances that are not essential for sustaining the life of a given organism.  
The dedicated study of secondary metabolites (also known as natural products) from 
terrestrial plants only began in the 1800s, where scientists were able to utilise novel 
scientific techniques to isolate, purify, and define these active compounds.  The efforts 
of scientists in these studies also laid the platform for modern-day synthetic organic 
chemistry.     
Many important modern medicines used for treating a variety of diseases, and in other 
medicinal purposes, can be attributed to these biologically active secondary 
metabolites, isolated from terrestrial sources.  In 1805 the narcotic analgesic morphine 
(1), was isolated from the opium poppy Papaver somniferum.3  Extensive structural 
studies eventually led to the elucidation of morphine’s structure in 1925.4  In 1820, 
quinine (2) was isolated from the bark of the Chinchona sp., a tree indigenous to 
certain regions of South America.1,4  Quinine has been described as the first effective 
anti-malarial compound found, paving the way for the synthesis of the commonly used 
anti-malarial drugs chloroquine (3) and mefloquine (4).5   
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From the bark of the willow tree (Cortex salicis) the main bioactive compound salicin 
(5) was discovered in the mid 1800’s.  However, it was the derivatives, salicylic acid (6) 
and acetylsalicylic acid (aspirin, 7) which showed improved medicinal properties.  This 
led to the commercialisation of aspirin in 1899.6  Over 100 years later, aspirin features 
as the most successful drug worldwide to be derived from a bioactive secondary 
metabolite.6 
 
The chance discovery of penicillin G (8) from the filamentous fungus Penicillium 
notatum by Alexander Fleming in 1929, and the realisation of its broad therapeutic 
uses in the 1940s, prompted intensive investigation of nature as a source of novel 
bioactive natural products.1-2,7  Since the 1940s micro-organisms and, to a lesser 
degree, terrestrial plants have been excellent sources of antibiotics.8  Growing 
concerns in the medical field stemming from drug resistant bacteria and the discovery 
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of new pathogens has meant that the search for novel bioactive products has 
expanded to encompass the marine natural environment.   
 
1.2. Marine Natural Products 
More than 70% of the Earth’s surface is covered by oceans and life itself has its origins 
in that marine environment.9  Furthermore, 34 of the 36 known phyla of living 
organisms come from an aquatic environment, which offers a greater biodiversity than 
that of the terrestrial environment.  The large marine biodiversity has evolved to 
endure the harsh and extreme conditions in which it inhabits such as variable 
temperatures, currents, wave action, pressures and high salinity. 
Throughout history, the use of marine organisms has played a very small part in the 
development of traditional medicines and is therefore not as heavily documented as 
its terrestrial counterparts.  This was largely due to the accessibility issues of marine 
flora and fauna in all but the shallowest of waters.  The scope and potential of marine 
natural products therefore remained unknown until the 1940s.  The design and 
development of the first inexpensive and reliable SCUBA apparatus, by Jacques 
Cousteau in 1943, allowed for the routine collection of marine organisms at depths of 
down to 35 m.10 
The first marine-derived natural products to be isolated and identified were the 
biologically active nucleosides, spongothymidine (9) and spongouridine (10) from the 
Caribbean sponge Crypotethya crypta, in the early 1950s.11-13  After the discovery of 9 
and 10 interest grew in the field and further research led to the development of the 
synthetic analogues Ara-C (cytosine arabinoside, 11), the first marine-derived anti-
cancer agent, and the anti-viral agent AZT (azidothymidine, 12).14-15  However, it was 
not until the 1970s that marine natural products (MNP) emerged as a fully fledged 
discipline.16  
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Since then marine natural products chemists have sought novel biologically active 
secondary metabolites through the investigation of several types of marine organisms, 
including sponges, nudibranchs, soft corals and algae.  As of 2010, marine natural 
products or derivatives thereof have provided four approved drugs, 13 in clinical trials 
and several at various stages of preclinical studies.17  More recently, as of early 2012, 
the MarinLit database has suggested that more than 24,000 marine natural products 
have been described.18   
 
Prialt (ziconotide, 13) was the first “direct from the sea” compound to be approved by 
the FDA and become a licensed pharmaceutical.  Ziconotide was isolated from the 
venom ducts of the predatory cone snail of the genus Conus magus.19  The compound 
is the synthetic equivalent of the ω-conopeptide MVIIA which is a 25 amino acid 
peptide chain.20  Ziconotide is a very potent and highly selective blocker of mammalian 
neuronal N-type voltage-sensitive calcium channels inhibiting the activity of a subset of 
neurons including pain-sensing primary nociceptors.20  These properties make Prialt a 
potent non-opioid analgesic, currently in use for the management of severe chronic 
pain.20 
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1.3. Marine Organisms 
Marine organisms, that are typically soft-bodied and/or sessile, like macro-algae and 
sponges (discussed in more detail in Chapters 2 and 3 respectively) were, and still are 
of interest to marine natural product chemists.  This interest comes from the potent 
chemical defence mechanism these organisms have attained, either through evolution 
or a symbiotic relationship.9   This chemical defence mechanism consists of bioactive 
secondary metabolites that act as a deterrent when excreted by the organism.  These 
natural products become immediately diluted as they are released into the ocean 
environment and therefore must be highly potent to have the desired effect.9 
Sponges, in particular, are well known to form symbiotic relationships with large 
communities of micro-organisms.  Symbiotic functions that have been attributed to 
this relationship include nutrient acquisition, stabilisation of sponge skeleton, 
processing of metabolic waste and secondary metabolite production.21  Some studies 
have been conducted demonstrating that symbiotic marine micro-organisms, 
harboured by sponges, are the original producers of some of the bioactive secondary 
metabolites isolated from sponge samples.22 
1.4. The New Zealand Marine Eco-region 
The marine natural products group at Victoria University of Wellington (VUW) has 
performed extensive studies on New Zealand marine organisms.  New Zealand has an 
extremely biologically diverse marine environment, influenced by its geographical 
location, range and complexity of habitats, and the number of major ocean currents 
that pass within its Exclusive Economic Zone (EEZ), see Figure 1.1.23  New Zealand’s EEZ 
has an area of 4.2 million km2 spanning over 30o of latitude from subtropical to sub-
Antarctic waters, and extending from shallow waters to the deep sea.24  New Zealand’s 
marine environment is home to an estimated 23,000 species of which approximately 
12,000 have been identified.24 
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Figure 1.1 Map of New Zealand highlighting the EEZ boundary (outlined in black).  Image 
courtesy of Land Information New Zealand (LINZ).23 
Between 1979 and August 2012 the MarinLit database accumulated records on 410 
natural products isolated from New Zealand marine organisms.18  One such study of 
the New Zealand sponge Mycale hentscheli provided the isolation of the polyketide 
derived compounds, mycalamides (14-16) and pelorusides (17-18).25-29  Studies of 
Raspailia sponge species have also led to the isolation of several novel compounds, 
discussed in Chapter 3.  New Zealand red algae studies have led to the isolation of 
novel compounds, across several classes, including the acetogenins (19-21) and 
sesquiterpenes (22-23).30  Further red algae natural products have been reported with 
some mentioned in Chapter 2. 
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1.5. The Tongan Marine Eco-Region 
Recently the group has changed direction and is now focussed on studies of marine 
organisms from the Kingdom of Tonga as opposed to New Zealand.  The Kingdom of 
Tonga is located 2000 km northeast of New Zealand and consists of 171 islands of 
which 36 are inhabited, see Figure 1.2.31  Tonga is located between 18o and 22o S 
latitude and 173o and 176o W longitude, and is divided into three main island groups; 
Vava’u in the north, Tongatapu and ‘Eua in the south with Ha’apai in between.  Tonga 
has a total land area of 688 km2 with an EEZ over 1000 times larger at 700,000 km2 
which provides a large diverse marine environment in which studies could be 
undertaken.  Tonga was of interest to the VUW marine chemistry group as the tropical 
conditions gave rise to different species of marine organisms which could be found in a 
variety of habitats, including coral reefs, which are not found in the colder waters of 
New Zealand.  The Tongan islands were also chosen as, until recently, access had been 
limited and as such, there had been very few reports of secondary metabolites isolated 
from Tongan marine organisms. Two dives were conducted in different regions, to 
collect and study various marine organisms.  One particular dive collection was 
performed around the southern coastline of the island of ‘Eua, where several sponge 
species were found.   
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Figure 1.2 The Tongan Kingdom, courtesy of NationMaster.31  
A study by Taufa, on sponges of the order Dictyoceratida, saw the isolation of the 
novel sesterterpenes, isoluffariellolide (24) and 1-O-methylisoluffariellolide (25) from a 
Fascaplysinopsis sp., and the compound secothorectolide (26) from an undescribed 
species.32  Biological testing showed that 24-25 exhibited micromolar cytotoxicity 
against the human promyelocytic leukaemia (HL-60) cell line while 26 displayed 
micromolar cytotoxicity towards ovarian cancer cells.32  A study by Barber saw the 
isolation and identification of seven novel metabolites of polyketide origin, lehualides 
E-K (27-33) from a Plakortis sponge specimen.33  Biological testing showed that 28-31 
displayed micromolar cytotoxicity against the HL-60 cell line.33  The isolation of 
compounds 24-33 and subsequent biological activity studies indicate that Tongan 
sponges contain numerous new and structurally diverse bioactive secondary 
metabolites and as such, research into tropical marine organisms has become 
commonplace at VUW.  There have however, been limited studies into Tongan marine 
red algae suggesting the potential for further novel compound isolation.  
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1.6.  Fractioning of a Crude Extract 
Crude extracts, concentrated solvent solutions (typically methanol or ethanol) 
obtained from the extraction and subsequent filtration of an organism, have proven to 
be difficult to analyse and handle due to wide polarity and solubility ranges.  Initial 
purification of a crude extract has over the years seen changes in methodology from, 
the straightforward technique of liquid/liquid partitioning to column chromatography.  
A reversed-phase chromatography procedure was developed by Blunt and Munro 
utilising a solid support of octadecyl-derivatised silica (C18) and a low pressure 
chromatographic technique which was found to overcome problems associated with 
using standard flash chromatography (normal phase).34  Figure 1.3 is a hypothetical 
graph showing the mass distribution of a typical New Zealand marine organism crude 
extract eluted off a reversed-phase solid support.  The target secondary metabolites 
are typically found at intermediate polarities as they often have complex structures 
that contain both polar and non-polar entities (amphiphilic). 
 
Figure 1.3 Diagram of the mass distribution of a typical New Zealand marine organism extract 
off a reversed-phase support. 
However, Blunt and Munro’s procedure did encounter some difficulties as the 
procedure could not be performed on a large scale and significant amounts of extract 
were difficult to concentrate onto a solid support of finite size.  Additionally the C18 
solid support is not reusable as continued elution with highly aqueous solvents strips 
the beads of the octadecyl chains exposing uncapped silanol groups, making it a 
potentially costly procedure while also compromising reproducibility.35     
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At VUW, West and Northcote developed a variation of the Blunt/Munro method for 
fractioning a crude sample, cyclic loading, which was done on poly(styrene-
divinylbenzene) (PSDVB).36  PSDVB is a rigid and macroporous highly cross linked 
polymer that was used as the stationary reversed-phase support in favour of C18.  
PSDVB was found to have the advantages of being relatively inexpensive and unlike 
C18 reusable due to being chemically inert with no surface ligands that could be 
stripped off the column during use.35  See Appendix A for the cyclic loading process. 
1.7. Screening Techniques 
The most commonly used method for screening crude extracts for new natural 
products is bioassay-directed isolation which involves testing fractions of an extract for 
a specific activity.  An extract that provides positive biological activity is iteratively 
fractionated, with the collected fractions being tested against the same assay, tracking 
the activity until a pure compound is isolated.  In the 1990s, a bioassay-directed 
approach to isolation and identification of a biologically active compound was often 
challenging, expensive and slow.  One of the major reasons for this was that the 
investigator had total dependence on a suitable bioassay that will show some effect 
when screening crude extracts and subsequently guiding the isolation and separation 
procedure.35  Bioassay-directed isolation remains the dominant paradigm in the field 
of natural products isolation, backed strongly by the pharmaceutical industries desire 
for novel compounds that contain targeted bioactivity against certain diseases.   
During the 1990s, NMR-based screening methods were developed, on the back of 
many advances in spectroscopic techniques and in particular, high-resolution NMR 
techniques.  This revolutionised the determination of compounds re structural 
complexity, for example secondary metabolites.37  The important NMR advances 
related to natural product structure determination fell into two categories; 
multidimensional pulse methods and sensitivity improvements.37  An array of 
experimental methods have become available through continuous development and 
expansion of high-resolution two-dimensional NMR spectroscopy.  Multidimensional 
experiments, such as correlation spectroscopy (COSY), heteronuclear single-quantum 
coherence spectroscopy (HSQC) and heteronuclear multiple-bond correlation 
spectroscopy (HMBC), provide through-bond correlations affording a wealth of 
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molecular connectivity data utilised in defining the structure of interest.  Sensitivity 
improvements have also been vital in the continual development of NMR-based 
screening.  The advances in cryogenic electronics and micro-probe technologies has 
aided in increasing the resolution, and reducing the amount of material required to run 
a successful NMR spectrum, to less than a milligram.37 
NMR-based screening also answers a few of the problems associated with bioassay-
directed screening.  The NMR method is not looking at bioactivity and is therefore, not 
prone to being narrowly focussed, as several novel structures can be highlighted 
concurrently.  Each structure can have their own distinct biological activity tested 
separately.  Structural novelty can be known early on in the purification process 
allowing more thought-out purification steps to be conducted, with full structural 
elucidation being achieved earlier than in the bioassay method.  Finally, an NMR 
method is not destructive as most of the material can be recovered from the 
purification process which is significant when dealing with small samples.  It should be 
noted however, that an NMR guided isolation procedure is relatively insensitive 
compared to bioassay-directed isolation and the activity of the compound isolated is 
not known until after purification.   
1.8.  VUW Protocols 
Marine natural products chemistry has been an on-going area of research at VUW 
since the mid-1990s with an NMR-guided isolation procedure being used to identify 
and isolate secondary metabolites from marine sources.  Over the years the screening 
protocol has seen advancements that have made early determination of interesting 
marine organisms easier to achieve.  The first in-house screening procedure was 
introduced in the late 1990s with the structure and novelty of a compounds 
functionality becoming the primary interest.  Initial work utilised 1D 1H NMR spectra to 
guide the isolation of novel compounds from a crude sample which led to the isolation 
of several novel compounds including 17.28,36   
There were, however, limitations associated with the 1H NMR experiment that 
affected its widespread application.  The spectral crowding of crude extracts in the 1H 
NMR spectrum, at shifts below 5.5 ppm, due to overlapping primary metabolite 
resonances, meant that secondary metabolites with no deshielded proton shifts would 
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not appear in the 1H NMR protocol.  A new screening protocol was developed using 
the 2D HSQC NMR experiments to more widely identify secondary metabolites from 
semi-purified extracts.  The introduction of a second dimension allowed better 
separation of the primary metabolite resonances from upfield secondary metabolite 
resonances while also providing extra chemical information about the compound.  
Using West’s pre-screen semi-purification step, the revised screening protocol was 
analysed using the three NMR experiments (1H NMR, COSY and HSQC).35 
Utilising 2D HSQC NMR it became possible to collate a number of generated screens to 
produce a mask, which showed the positions of correlations related to primary 
metabolites.  This was first observed with the use of a paper mask where a subsequent 
screen was overlaid on the relevant mask with any unusual correlations noted.35  
Digital HSQC compiling software was later developed, allowing for an increased 
number of screen spectra to be incorporated into the mask while also eliminating most 
of the human error and time required superimposing the spectra in a paper mask.38-39  
The HSQC spectral masks generated for New Zealand sponges and red algae proved 
highly useful in organism selection and subsequently led to the isolation of several 
novel biologically active secondary metabolites (Wojnar and Singh PhD theses and.40-42  
Figures 1.4 and 1.5 illustrate the HSQC mask of 34 New Zealand algae samples 
(Popplewell study) with frequent correlations seen in white and less frequent 
correlations seen in blue.40  By masking out the common white correlations it becomes 
easier to assess the degree of structural novelty present in a given spectrum.                     
 
Figure 1.4 An HSQC mask of 34 NZ algae specimens.40 
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Figure 1.5 Common correlations seen in the NZ algal HSQC mask.40 
From several sponge collections around New Zealand the HSQC mask began to show 
that a given screen exhibited correlations only consistent with compounds already 
isolated in the lab.  This suggested that the same sponge organisms were being 
collected.  At this point a decision was made that led to three different pathways being 
undertaken in-house; the collection and study of sponge organisms from Tonga 
(mentioned previously), the study of New Zealand red algae and an HMBC digital mask 
was considered. 
New Zealand Red Algae Studies 
At the same time as Tongan sponge studies were going on, New Zealand marine red 
algae were being looked at, as an alternative source of interesting and novel secondary 
metabolites.  A study by Popplewell found that the standard protocol for the screening 
of sponge extracts through 2D experiments, discussed previously, was easily adapted 
to New Zealand macro-algae.40  Red algal fractions were, on average, slightly richer 
compared to those of the New Zealand sponge extracts studied (comparison between 
equal 100 g wet weight extractions) which meant less initial sample was required.40  A 
number of samples were screened and a digital HSQC mask was generated (Figure 1.4) 
which afforded easier determination of samples to be studied in further detail.  
Further mention of this study is given in Chapter two. 
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The HMBC Screen 
The third development that was taken by the VUW marine natural products group was 
the advancement in the screening protocol used to determine whether prospective 
organisms contain potentially novel secondary metabolites.  While the HSQC screen 
has been a tool successfully used in the lab at VUW for the use in isolating novel 
secondary metabolites with diverse structures it does have its limitations.  It does not 
inherently detect non-protonated functional groups, for example nitriles and non-
protonated olefinic carbons and no direct evidence is provided that indicates that any 
of the correlations observed, belong to a single molecular entity.   
A further advancement implemented in-house involved the screening for 
substructures within the crude extract.  The HMBC experiment, first proposed in 1986, 
provided multiple-bond correlations between 1H and 13C nuclei.43  The HMBC 
experiment is a less sensitive experiment than the HSQC, however it is a more 
powerful experiment due to the wealth of structural information it provides.  
Substructure screening can be achieved using the quicker COSY experiment however 
this only shows correlations of protonated carbons in a sequence but generally does 
not allow for non-protonated carbon linkages in the sequence.  Additionally the COSY 
provides less spectral dispersion as the second dimension is derived from the same 1H 
nucleus.   
The identification of families of compounds at an early stage of purification could be 
possible with a functional HMBC screen which would be very useful after just a single 
fractionation.41  This would allow early determination, in the isolation process, of 
whether the organism has potential and is worthy of further study or whether it should 
be disregarded.  The running of an HMBC screen concurrently with an HSQC screen can 
provide a wealth of information, allowing interesting one-bond correlations, observed 
in an HSQC, to be extended to multiple-bond correlations through an HMBC screen 
further leading to a possible substructure determination.  An HMBC experiment does 
however, require a longer acquisition time to generate high resolution data as it is 
looking at nJCH coupling (where n = 2, 3, 4 or 5) which is considerably weaker than the 
1JCH coupling observed in HSQC experiments.   
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1.9. Research Aims 
This study will analyse Tongan algae with specimens screened and purified for novel 
secondary metabolites.  The concentration and structural diversity of Tongan algae will 
be compared with that of the previously studied temperate NZ algae, to ascertain 
whether the same results are seen as was observed in sponges (discussed in Chapter 
2).  NMR guided isolation will be applied to lead the chromatographic process and the 
HMBC screen will be used to identify molecular substructures early in the purification 
process.  A study of a New Zealand Raspailia sponge sample will be performed to 
determine whether the HMBC screening protocol of previously disregarded sponge 
samples brings about the isolation and structural elucidation of novel compounds.  
Novel samples will be submitted for biological activity studies with the aim of 
identifying compounds with interesting biological activity. 
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Chapter 2  
 
Tongan Marine Algae Study 
2.1. Seaweed – Marine Macro-Algae 
Seaweed, or marine macro-algae, are ancient organisms that make up a large 
proportion of the world’s marine flora.  Global utilisation of macro-algae is a multi-
billion dollar industry, based on the farming of edible seaweed and its uses in the 
production of agar, carrageenan and alginate.44  The form of the algae plant body 
varies, from the relative simplicity of a single cell, 1.5 µm in size, to kelps, some of 
which may reach lengths of up to 60 m.45  Algae are very abundant organisms found in 
either aquatic or intertidal habitats with aquatic species growing in both fresh and salt 
water.  Some algae have been found in locations where the salinity reaches high levels 
in the dry seasons, whereas other algae that live on the hulls of ships, are remarkably 
tolerant to both fresh and saline water.45 
Marine macro-algae are traditionally split into the three phyla Chlorophyta (green), 
Phaeophyta (brown) and Rhodophyta (red) based on colour which is affected by the 
composition and amount of photosynthetic pigments, see Figure 2.1.40,45  Algae are 
polyphyletic - they do not fall within a single group linked by a common ancestor.  Red 
and green algae are classified under the kingdom Plantae, while brown algae are 
classified under the kingdom Chromista.  Typically, macro-algae are sessile and as a 
consequence have developed, through evolution, a chemical defence mechanism using 
bioactive secondary metabolites.  
As seaweeds are typically found close to shore in shallow waters, the ease of 
accessibility meant they were among the first group of marine organisms to be 
investigated by marine natural products chemists.  Prior to early work on marine algae, 
the medicinal properties of seaweeds had been demonstrated in traditional and folk 
medicines.  However, it was not until the 1970s that algae, along with other marine 
organisms, were looked at as a vast resource for the discovery of potentially useful 
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secondary metabolite natural products.  Between 1977 and 1987 algae was believed to 
be the source of 35% of the newly discovered chemicals over that time span.46 
 
Figure 2.1 A selection of brown, red and green marine algae at low tide. 
Early studies found tropical green algae (Chlorophyta), along with a few temperate 
relatives contained a number of biologically active secondary metabolites.  An early 
characteristic feature of green algal metabolites was the 1,4-diacetoxybutadiene 
moiety reported in more than half of the compounds isolated before 1984.47  
Numerous research groups around the world undertook much of the early work on 
Chlorophyta samples, isolating a number of these 1,4-diacetoxybutadiene containing 
compounds.47-54  The simplest of these was flexilin (34), isolated from Caulerpa flexilis 
in 1978.48  Two closely related 1,4-diacetoxybutadienes, caulerpenyne (35) and 
rhipocephalin (36), were subsequently isolated from Caulerpa prolifera and 
Rhipocephalus phoenix, respectively.49-50  Other functionalities observed in early green 
algae metabolites included a trialdehyde compound halimedatrial (37), produced by 
several species of the genus Halimeda.55-56  Halimedatrial showed diverse and potent 
biological effects, including inhibiting growth of marine fungi and bacteria.  Caulerpa 
prolifera was also found to contain several linear triterpenoid squalene derivatives 
including 38-40.57  Cymopol (41) and Cyclocymopol (42), along with their monomethyl 
ethers (43-44), were early examples of brominated hydroquinones isolated from 
Cymopolia barbata.58-59 
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Natural product chemists conducted extensive early studies into brown algae 
(Phaeophyta) and the many classes of metabolites they contained.  These classes 
ranged from simple lipids to more complex polymeric phenolics, called phlorotannins.  
Glombitza and co-workers performed extensive research into isolating phlorotannins 
(isolated and purified in their peracetylated form) from brown algae.60-66  This included 
undecafuhalol octacosa-acetate (45), the largest of the polymeric phenols to be 
defined during their research at the time, isolated from Bifurcaria bifurcate.64  The 
tropical brown alga Stypopodium zonale was found to excrete a rust-coloured 
substance that rendered seawater toxic to fish.  The excretion turned out to be the 
orthoquinone stypoldione (46), the aerial oxidation product of stypotriol (47), which is 
the more toxic of the two compounds.67  The algae specimen was found to also contain 
stypodiol (48), epistypodiol (49).67-68  The order Dictyotales was also studied with 
isolated compounds typified by the presence of diterpenes and, to a lesser extent, 
sesquiterpenes.  One family of diterpenes are ‘spatanes’, which contain a diterpene 
analogue of the bourbonene skeleton.  Spatol (50), obtained from Spatoglossum 
schmittii, was the first metabolite of the spatane series to be described.69  Spatol 
showed potent cytotoxicity in the urchin egg assay, which was believed to be 
associated with the 1,3-diepoxide moiety in the side chain.69  Several more studies in 
the early 1980s found more diterpenoid spatanes from other brown algae sources.47  
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Early studies into red algae (Rhodophyta) found that they contained a vast array of 
halogenated lipids, monoterpenes, sesquiterpenes and diterpenes.  Halogenated 
monoterpene isolates included two antimicrobial metabolites from Plocamium 
cruciferum discovered by Blunt, Munro and co-workers.70-71  They were shown to be a 
polyhalogenated monoterpene (51) and a bisnormonoterpenoid (52).  Halogenated 
sesquiterpenes, such as the chamigrenes, were discovered frequently in early red 
algae analysed.  Such chamigrenes included glanduliferol (53), isolated from Laurencia 
glandulifera.72-73  The halogenated selinanes represented a more distinct group of 
compounds from the genus Laurencia.  The compound (1S,4R,7R)-1-bromo-4-hydroxy-
7-chloroselinane (54) was found in an undescribed Australian Laurencia species.74   
Along with the work on halogenated monoterpenes, Blunt, Munro and co-workers 
discovered the unusual squalene derived metabolite thyrsiferol (55) from the red alga 
Laurencia thyrsifera.75  Thyrsiferol was subsequently found to exhibit inhibition in 
human breast tumour cell lines.76  Some non-halogenated metabolites were found in 
early studies including macrocyclic lipids such as (56), which was isolated from 
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Phacelocarpus labilladieri.77  The γ-pyrone was found to have a macrocyclic acetylene-
containing ring cyclised through an enol ether linkage. 
 
In the mid 1980’s, marine natural products chemistry became more bioassay driven 
with a particular emphasis on mammalian cell cytotoxicity in the hope of finding anti-
cancer compounds.  The study of algae diminished in favour of marine sponges and 
tunicates, the extracts of which showed higher cytotoxicity in these bioassays.  
Recently, as structurally driven marine natural products have become more widely 
utilised, macro-algae studies have been rejuvenated by several natural products 
groups leading to the discovery of further novel compounds, with interesting 
bioactivity.  Algal collections from tropical, temperate and polar regions78 have proven 
to be a good source of novel compounds with much structural diversity.  Annual 
reviews from the last 10 years have stated that the number of secondary metabolites 
reported from green algae have been in decline each year while brown algae 
secondary metabolite numbers reported have been in decline since 2009.  However, 
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the number of compounds from red algae, which saw a decline in 2008, has picked up 
again in recent years.79-80 
Novel green algae secondary metabolites reported in recent years have largely been 
from a single family of compounds, the kahalides, isolated entirely from Bryopsis 
pennata.  The two most recent kahalides reported were two cyclic depsipeptides 5-
OHKF (57) and norKA (58).81  One member of the kahalide family, kahalide F (59) has 
been under active development as an anti-cancer drug and has reached phase two 
clinical studies.81   
Terpenes and polyphenols are the dominant classes of secondary metabolites isolated 
from brown algae.  Novel phlorotannins also continue to be isolated, including 
diphlorethohydroxycarmalol (60) from Ishige okamurae.82  Compound 60 was found to 
possess radical-scavenging activity in addition to potent inhibition of α-glucosidase and 
α-amylase, with possible potential as a functional food or nutraceutical for diabetes. 
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Red algae continue to be a prolific source of polyhalogenated secondary metabolites, 
while more recently, other classes have been reported including oxylipins and 
bromophenols.  Oxylipins (or eicosanoids), such as 61 and 62 isolated from 
Rhodymenia pertusa, and labillarides A-K (63-73) isolated from Phacelocarpus 
labilladieri, have been found.40,83  Compounds of this nature are derived from fatty 
acids by pathways involving at least one step of dioxygen-dependent oxidation.83  
Biosynthesis of oxylipins is initiated by lipoxygenase enzymes.84  Products of the 
lipoxygenase pathway, in mammalian tissues, are pivotal signalling molecules in many 
physiological and pathophysiological conditions including asthma.85  Bromophenol 
compounds, such as 74 from Symphyocladia latiuscula have also been isolated 
recently.86  These compounds are of interest as they show nitrite scavenging, α-
glucosidase inhibition, antioxidant, feeding-deterrent, anti-inflammatory and aldose 
reductase inhibitory activities.  
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2.2. VUW Algal Studies 
Popplewell’s previous study was undertaken in the marine natural products group at 
VUW, examining 34 temperate New Zealand red algae for the presence of novel 
secondary metabolites.  Across the 34 samples, examined with the VUW HSQC 
screening protocol, four showed interesting signals that were studied in further detail.  
From two of these samples, distinctive signals were observed consistent with known 
monoterpene and indole-containing compounds.  Purification of the other two 
samples led to the isolation of the aforementioned novel macrolides, labillarides A-K 
(63-73) from Phacelocarpus labilladieri and the novel nitrogenous bromophenol, 
colensolide A (75) from Osmundaria colensoi.40,87  Biological testing of the labillarides 
showed that 63, 64 and 71 showed moderate cytotoxicity while 65 showed moderate 
antibacterial activity.  The successful study showed the prominence of novel secondary 
metabolites in New Zealand algal samples. 
 
The marine natural products laboratory at VUW has, over the last few years, expanded 
its marine organism collection sites, from the temperate waters of New Zealand to the 
tropical waters of Tonga.  Tropical algae that had been collected across two dive trips 
to Tonga had not yet been studied, however, work conducted in house with tropical 
sponges had found that they possess a higher concentration of secondary metabolites 
along with more structural diversity than their temperate counterparts.  During this 
study a variety of red, brown and green algae, from Tongan sources, were assessed. 
 
 
27 
   
2.3. Algae Screening 
In this study, a total of 11 algae were screened using the HSQC screening protocol.  
Additional HMBC spectral data was obtained for each sample and a computer based 
mask was generated using software developed in the marine natural products group at 
VUW.39  The mask initially revealed similarities between several samples indicating 
similar compounds within multiple samples.  The results of the 11 screens, of the 
medium polarity crude extracts (75% Me2CO in H2O sample) are summarised in Table 
2.1.  Additional discussion is provided for samples PTN4_17G, PTN4_18E and 
PTN3_38C, which contained the most interesting NMR resonances. 
 
Table 2.1 Summary of the screening of 11 algae samples. 
Algal Sample Collection Site 
Algae Type 
(Colour) 
Presence of a Common 
Glyceroglycolipid 
(Oxymethine and sp
2
 
resonances)  
Additional Strong Signals 
     
PTN4_17G Houma Blowholes, Tongatapu green yes - 
PTN4_18C Houma Blowholes, Tongatapu red yes - 
PTN4_05H Hunga Magic, Vava'u red yes - 
PTN4_13F Ledges, Vava'u red yes - 
PTN3_33A Ano Beach, Vava'u brown yes - 
PTN3_33B Ano Beach, Vava'u brown yes - 
PTN3_33C Ano Beach, Vava'u brown yes 
Resonances in the δc 40 – 80 
ppm and δH 1 – 2 ppm range. 
PTN4_18E Houma Blowholes, Tongatapu brown yes methylidene functionality 
PTN4_17D Houma Blowholes, Tongatapu red yes 
Downfield carbonyl 
functionality 
PTN4_18D Houma Blowholes, Tongatapu brown yes - 
PTN3_38C Split Rock, Vava'u red yes Aromatic resonances 
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2.4. The Common Glyceroglycolipid – PTN4_17G 
As seen from Table 2.1, all 11 of the algae specimens screened showed oxymethine 
and sp2 resonances characteristic of glycolipid compounds.  Upon comparison with 
other screens in this study, it was apparent that most of the characteristic glycolipid 
signals were identical between species.  Interestingly these common resonances were 
not prominent in any of the previously screened New Zealand algae, so an 
investigation of these signals was initiated.  PTN4_17G was the first algae sample 
screened in this study that showed these glycolipid characteristics.  The sample was 
subjected to further purification steps in order to determine the structure of the 
common metabolite. 
PTN4_17G, an unidentified green alga, was collected from the Houma blowholes on 
the Tongan island of Tongatapu.  Analysis of the 1D and 2D data of the crude sample 
showed the presence of resonances attributable to a number of oxymethine protons 
(δC 60-80, δH 3-5), carbonyl carbons (δC 160-180) and sp
2 carbons.  Further purification 
involved firstly stepwise elution from H2O through to MeOH on a 2 ml HP20ss column 
and secondly, stepwise elution from CH2Cl2 through EtOAc to MeOH on a 2 ml DIOL 
column.  The sample came off the HP20ss column in 100% MeOH and also came off 
the DIOL column in MeOH.  The full molecular formula for the compound was not 
possible as mass spectrometry did not provide a relevant [M+H]+ pseudomolecular ion 
peak. Therefore full determination of the molecular formula and structure was unable 
to be attained.   
Analysis of the spectra revealed that the unknown glycolipid compound contained a 
single sugar moiety.  Six signals were observed in the HSQC consisting of one anomeric 
(CH-1’ δC 99.8, δH 4.76), four oxymethines (CH-2’ δC 73.3, δH 3.40, CH-3’ δC 74.7, δH 
3.63, CH-4’ δC 74.8, δH 3.08, CH-5’ δC 69.7, δH 4.07) and one deshielded methylene 
(CH2-6’ δC 54.0, δHa 3.35, δHb 2.92).   
A series of COSY correlations observed (H-1’ to H-2’, H-2’ to H-3’, H-3’ to H-4’, H-4’ to 
H-5’, H-5’ to H-6’a, H-5’ to H-6’b and H-6’a to H-6’b), revealed a linear carbon chain 
typical of a sugar moiety, represented in Figure 2.2.  The unusual carbon and proton 
shifts of CH2-6’ (δC 54.0, δHa 3.35, δHb 2.92) revealed that this position was not a 
standard pyrano-hexose oxymethylene.  The upfield shift in the carbon dimension 
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indicated the presence of an amino functionality attached to position six, as shown in 
Figure 2.2.  This aminomethylene six position signal was observed in all the sample 
screens and showed no further correlations suggestive of amide functionality at the 
position.  Tabulated NMR of PTN4_17G is provided in Table 2.2. 
 
Figure 2.2 COSY correlations establishing a carbon chain consistent with a sugar moiety. 
Correlations observed in the HMBC experiment (H-1’ to C-2’, C-3’ and C-5’; H-2’ to C-3’; 
H-3’ to C-2’ and C-4’; H-4’ to C-3’, C-5’ and C-6’; H-5’ to C-4’ and C-6’; and finally H-6’b 
to C-5’) confirmed the COSY assignments.  The HMBC correlation observed from H-1’ 
to C-5’ revealed an ether linkage between C-1’ and C-5’ which established a 6-deoxy-6-
amino sugar moiety ring system seen in Figure 2.3. 
Further analysis of the 2D spectra revealed a second spin system that contained two 
oxymethylenes (CH2-1 δC 64.0, δHa 4.51, δHb 4.18 and CH2-3 δC 66.9, δHa 4.11, δHb 3.57) 
and an oxymethine CH-2 (δC 71.5, δH 5.31).  In the HSQC experiment CH2-1 was 
discerned due to its deshielded proton shifts.  COSY correlations were observed from 
H-1a,b to H-2 an oxymethine, which established a bond between C-1 and C-2.  The 
bond between C-2 and C-3 was determined by COSY correlations observed between H-
2 and H-3a,b.  No further COSY correlations were observed which indicated that C-1, C-
2 and C-3 made up a glycerol subunit.  Analysis of the HMBC spectrum revealed 
correlations from H-1’ to C-3 and H-3a,b to C-1’ which indicated that the glycerol 
subunit was attached to the sugar moiety through C-1’, as shown in Figure 2.3.  This 
indicated that the common compound seen across most of the algal screens was a 
glyceroglycolipid.  The coupling constants of H-1’ (3.7 Hz) and H-2’ (9.7 and 3.8 Hz) 
could be determined which provided evidence that H-1’ was equatorial therefore the 
linkage between the sugar moiety and the glycerol moiety was determined to be an α-
linkage. 
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Figure 2.3 COSY and HMBC correlations establishing glycerol functionality attached at C-1'. 
HMBC correlations were observed from H-1a,b to a carbonyl C-1’’ (δC 174.9) which 
confirmed the presence of an ester functionality, illustrated in Figure 2.3.  Although it 
was not observed, the chemical shift of H-2 (δH 5.31) was consistent with the 
attachment of an acyl unit (approximate 1 ppm downfield shift from expected if the 
functional group was a hydroxyl).  Due to inconclusive mass spectrometry data the 
fatty acid chain lengths could not be determined.   
The full relative stereochemistry of the sugar moiety was determined using the 
coupling constants of the protons around the ring system.  The anomeric proton H-1’ 
was observed to be a doublet with a coupling constant of 3.7 Hz which is indicative of 
an axial-equatorial relationship with H-2’.  Proton H-2’ was determined to be axial on 
the α face of the ring (therefore an α configuration at C-1’) as it was revealed to be a 
doublet of doublets with a large coupling constant of 9.7 Hz to H-3’, indicative of a 1,2-
trans diaxial relationship.  Proton H-4’ was observed to be a triplet with a coupling 
constant of 9.3 Hz which indicated a 1,2-diaxial relationship with H-3’, confirming that 
H-3’ was in an axial position on the β face.  A large coupling constant of 9.5 Hz was 
observed for the broad triplet H-5’ signal which confirmed that H-4’ was axial on the α 
face and therefore H-5’ was axial on the β face.  This confirmed that the sugar moiety 
contained α-D-glucose stereochemistry, with the structure provided in Figure 2.4. 
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Figure 2.4 The relative stereochemistry of the aminosugar moiety of 76 determined by 
coupling constants. 
In general, glyceroglycolipids are common compounds isolated from higher plants and 
macro-algae.  Amination of sugar analogues is most commonly observed at the two 
position, in the form of 2-deoxy-2-amino (or 2-acetamido) sugar moieties, with such 
moieties seen in compounds distributed amongst different marine organisms.  
Glyceroglycolipid compounds containing the 6-deoxy-6-amino glucose moiety are 
considered to be extremely rare with isolation of such compounds sparsely reported.   
The first reported isolation of glyceroglycolipids containing the rare sugar moiety were 
strangulatosides (77-78), isolated in 2001 from rhizomes of the terrestrial Chinese 
herbaceous plant Serratula strangulata.88  The linolenoyl group is a polyunsaturated 
fatty acid containing 18 carbons and three double bonds.  The compound 
avrainvilloside (79) was isolated from the green alga Avrainvillea nigricans in 2005, 
collected in Prince Rupert Bay of Portsmouth (Dominica).89  In this particular study, 
avrainvilloside was found to be inactive in murine fibrosarcoma studies.89  Two 
separate studies of the terrestrial plants Desmodium gangeticum, 2005 and Ocimum 
sanctum, 2007 led to the isolation of an aminoglucosyl glycerolipid (80) and 
ocimumoside A (81) respectively.90-91  Compound 80 was found to exhibit in vitro 
antileishmanial and immunomodulatory activity.90  Most recently, a study of the brown 
algae Ishige okamurae led to the isolation of ishigoside (82) a potential free-radical 
scavenger against hydroxyl and alkyl radicals.92  
The main difference between compounds 79-82, apart from the differing fatty acid 
chain length, is that 80 contains a β-linkage between the glucose and glycerol moieties 
whereas 79, 81 and 82 contain an α-link at the same position.  As demonstrated by 
structures 77-82, these glyceroglycolipids only differ in their fatty acid chain lengths, 
although additional functionality off the amino centre is possible, as seen in 78.  The 
spectral data in this study confirms that the unknown glyceroglycolipid is similar to the 
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previously isolated compounds 79, 81 and 82, however the length and presence of sp2 
carbons in the purported fatty acid chains of 76 were unknown in this study. 
The presence of the glyceroglycolipid in most Tongan (sub-tropical) and seeming 
absence in New Zealand (temperate) algae is of interest as it poses questions about 
whether environmental factors play a role in primary metabolite production in algae 
specimens.  Detection of this metabolite in such high levels across red, brown and 
green tropical algae was another interesting outcome from this study that could not be 
explained without further investigation.  
 
 
 
 
 
 
33 
   
Table 2.2 13C (150 MHz) and 1H (600 MHz) NMR data (CD3OD) for 76. 
 
 
 
 
 
 
 
 
 
2.5. The Methacrylic Acid Moiety – PTN4_18E 
PTN4_18E, an unidentified brown alga, was collected at the Houma Blowholes on the 
Tongan island of Tongatapu.  A number of oxymethine resonances and sp2 carbon 
resonances were present in the 1D and 2D experiments run, matching resonances seen 
across most of the algal specimens.  Some additional peaks were of interest in the 
HMBC screen while the HSQC screen revealed the presence of a methylidene group 
which warranted further investigation. 
Two DIOL column purifications were performed allowing for structural elucidation of 
the compound to be achieved.  The first column involved stepwise elution from CH2Cl2 
to MeOH through EtOAc, while the second column was eluted stepwise from hexanes 
to MeOH through CH2Cl2.  From the 50% CH2Cl2 in hexanes fraction, spectral analysis 
was performed, elucidating 83.  The sample was submitted for mass spectrometry 
analysis, however, no relevant [M+H]+ was attained which left an unknown molecular 
formula.  Analysis of the HSQC experiment revealed that the terminal methylene group 
CH2-4 (δC 124.4, δHa 6.24, δHb 5.82) observed an allylic COSY correlation from H-4a,b to 
an oxymethylene group CH2-3 (δC 69.4, δH 4.21, 2H).  HMBC correlations were 
observed from H-4a,b to C-3 and C-1, a carbonyl carbon (δC 169.2); with the shift of 
this centre consistent with an α,β-unsaturated carboxylic acid.  Weak HMBC 
 
13
C 
  
1
H 
  
COSY HMBC 
Position δ (ppm) mult 
 
δ (ppm) mult J (Hz) 
 
(
1
H-
1
H) (
1
H → 
13
C) 
1a 64.0 CH2  
4.51 dd 12.1, 2.9 
 
1b, 2 1'', 3 
1b 
   
4.18 dd 12.1, 6.9 
 
1a, 2 1'', 2, 3 
2 71.5 CH 
 
5.31 m 
  
1a, 1b, 3a, 3b 
 
3a 66.9 CH2  
4.11 dd 10.8, 5.4 
 
2, 3b 1, 1', 2 
3b 
   
3.57 dd 10.8, 6.3 
 
2, 3a 1, 1', 3 
1' 99.8 CH 
 
4.76 d 3.7 
 
2' 2', 3, 3', 5' 
2' 73.3 CH 
 
3.40 dd 9.7, 3.8 
 
1', 3' 3' 
3' 74.7 CH 
 
3.63 
   
2', 4' 2', 4' 
4' 74.8 CH 
 
3.08 t 9.3 
 
3', 5' 3', 5', 6' 
5' 69.7 CH 
 
4.07 br t 9.5 
 
4', 6'a, 6'b 4', 6' 
6'a 54.0 CH2  
3.35 
   
5', 6'b 
 
6'b 
   
2.92 m 
  
5', 6'a 5' 
1'' 174.9 C 
       
1''' 174.7 C 
       
R undetermined 
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correlations were observed from H-3a,b to a non-protonated olefinic carbon C-2 (δC 
139.4).  This spectral data established the double bond between C-4 and C-2, and the 
single bonds from C-1 to C-2 and C-2 to C-3.  This confirmed the isolated substructure 
seen in Figure 2.5.  
 
Figure 2.5 COSY and HMBC correlations establishing the methacrylic acid moiety of 83. 
The assignment of a carboxylic acid functional group was confirmed with no additional 
HMBC correlations observed to C-1, apart from H-3a,b which suggested no ester 
functionality.  A spin system containing two oxymethylenes (CH2-5 δC 69.9, δH 3.65, 2H 
and CH2-7 δC 63.7, δHa 4.38, δHb 4.15) and an oxymethine CH-6 (δC 71.5, δH 5.24) was 
observed with COSY correlations (H-5a,b to H-6 and H-6 to H-7a,b) establishing a 
familiar glycerol subunit C-7 to C-6 to C-5.  HMBC correlations were observed from H-
5a,b to C-3, which established the link to the methacrylic acid moiety with additional 
HMBC correlations observed confirming the glycerol assignment, shown in Figure 2.6.  
An HMBC correlation was observed from H-7b to a carbonyl carbon C-8 (δC 174.7), 
which established ester functionality at that position.  The HMBC revealed methylene 
protons between δH 2-3 ppm and several methylene carbon resonances (consistent 
with a fatty acid chain) correlating into the same carbonyl indicating the possible 
presence of a fatty acid chain.  NMR data for 83 is provided in Table 2.3. 
 
Figure 2.6 COSY and HMBC correlations establishing the glycerol subunit of 83. 
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A study in 1981 of the brown alga, Sargassum fulvellum, isolated from Chiba, Japan 
described the isolation of novel types of glycerides bearing a methacrylic acid moiety 
(84-85), shown in Figure 2.7.93  On comparison with structural data of 84-85, the 
spectral data and structural elucidation of the compound isolated in this study was 
found to coincide (accounting for solvent differences).   
 
Figure 2.7 Elucidated substructure 83 along with known analogues. 
One significant difference from the literature suggested that two fatty acid chains may 
be present in 83 as a downfield shift of proton six was observed.  Given no suitable 
mass spectrometry data was obtained, NMR analysis alone could not confirm the 
presence of a second chain.  It was therefore not known whether the compound 
isolated in this study was compound 84 or 85, or indeed another fulvellic acid 
analogue.  The morphology of the Tongan brown algae sample in this study was 
consistent with algae of the species Sargassum. 
Table 2.3 13C (150 MHz) and 1H (600 MHz) NMR data (CD3OD) for fulvellic acid analogue 83. 
 
 
 
 
 
    * (w) indicates weak signals 
 
13
C 
 
1
H 
 
COSY HMBC 
Position δ (ppm) mult 
 
δ (ppm) 
 
(
1
H-
1
H) (
1
H → 
13
C) 
1 169.2 C 
     
2 139.4 C 
     
3a 70.7 CH2  
4.21 
 
4a, 4b 2 (w)*, 4 (w) 
3b 
   
4.21 
 
4a, 4b 2 (w), 4 (w) 
4a 125.7 CH2  
6.23 
 
3a, 3b, 4b 1, 3 
4b 
   
5.82 
 
3a, 3b, 4a 1, 3 
5a 69.9 CH2  
3.65 
 
6 3, 6, 7 
5b 
   
3.65 
 
6 3, 6, 7 
6 71.5 CH 
 
5.24 
 
5a, 5b, 7a, 7b 
 
7a 63.7 CH2 
 
4.38 
 
6, 7b 
 
7b 
   
4.15 
 
6, 7a 6, 8 
8 174.7 C 
     
R and R1 undetermined 
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2.6. Aromatic Proton Signals – PTN3_38C 
PTN3_38C, an unidentified red alga, was collected from Split Rock, in the island group 
of Vava’u, Tonga.  Analysis of the 1D and 2D screen spectra revealed resonances 
consistent with aromatic protons, sp2 carbons and oxymethines.  The presence of 
aromatic signals justified further purification as no previous algal sample investigated 
in this study had exhibited such resonances. 
Given the strong resonances in the screen spectra structural elucidation could be 
achieved from a sample semi-purified after one DIOL column with stepwise elution 
from CH2Cl2 to MeOH through EtOAc.  The molecular formula of 86 was determined to 
be C31H30O11N4Br6 from a positive ion mode HRESIMS measurement of the [M+Na]
+ 
pseudomolecular ion peak at m/z 1130.6895 (Δ -1.2 ppm).  The relative abundance of 
an isotope cluster from [M]+ to [M+12]+ provided evidence consistent with six 
bromines present in the compound.  The molecular formula required the structure to 
contain 16 double bond equivalents. 
Given the presence of distinguishable aromatic signals, structural elucidation 
originated at CH-15, CH-15’ (δC 131.6, δH 7.62), a single aromatic proton.  COSY data 
revealed a single correlation from H-15 to H-17, an oxymethine CH-17 (δC 71.4, δH 
4.76), a signal consistent with allylic coupling, illustrated in Figure 2.8.  Correlations 
were observed in the HMBC spectrum from H-15 to three non-protonated aromatic 
carbons C-13 (δC 153.1), C-14 and C-14’ (δC 118.7), and C-16 (δC 143.1) while also 
correlating to C-17.  An additional HMBC correlation indicated the presence of a 
carbon atom magnetically equivalent to C-15 within two to three bonds, C-15’.  This 
suggested the presence of a symmetrical tetra-substituted aromatic benzene ring, 
shown in Figure 2.8.  Substituent assignment around the ring was achieved by 
assessing the carbon shifts of C-13, C-14 and C-16 while also accounting for the 
determined symmetry.  Carbon 13 observed the largest downfield shift consistent with 
the high electronegativity of a bound oxygen functionality while carbon 16 observed a 
smaller downfield shift due to the lower electronegativity of a bound carbon 
functionality.  Carbons 14 and 14’ exhibited an upfield shift which suggested possible 
bromine attachment at these positions. 
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Figure 2.8 COSY and HMBC correlations establishing a symmetrical tetra-substituted aromatic 
ring in 86. 
Further COSY correlations from H-17 to H-18a,b revealed a methylene group, CH2-18 
(δC 47.5, δHa 3.49, δHb 3.40).  An HMBC correlation was observed from H-17 to C-18 
confirming a bond between C-17 and C-18.  Amide functionality was determined to be 
present, bound to C-18, due to HMBC correlations observed from H-18a,b to a 
carbonyl carbon C-9’ (δC 161.5) with a resonance consistent with an amide.  Protons H-
18a,b are characteristically downfield, indicating that the amide functionality is bound 
to C-18 through the nitrogen, as shown in Figure 2.9 (typically between 2-3 ppm if 
bound through carbonyl).  
A series of COSY correlations revealed a spin system containing an oxymethylene 
group CH2-12 (δC 75.7, δHa 4.04, δHb 3.99) bound to an oxymethine group CH-11 (δC 
69.8, δH 4.22) with CH-11 bound to a second methylene group, CH2-10 (δC 43.6, δHa 
3.72, δHb 3.50), establishing a carbon chain of C10-C11-C12.  HMBC correlations were 
observed confirming the carbon chain, with selected correlations shown in Figure 2.9.  
HMBC correlations from H-12a,b to C-13 revealed that the carbon chain was bound to 
the aromatic ring through an ether linkage.  This confirmed the symmetrical 
assignment of C-14/C-14’ and C-15/C-15’.  Further correlations were observed in the 
HMBC experiment from H-10a,b to C-9 (δC 161.6) a carbonyl carbon with a resonance 
consistent with an amide functionality.  The 13C and 1H shifts of CH2-10 were similar to 
CH2-18 which established that C-10 was bound through the amide nitrogen , illustrated 
in Figure 2.9. 
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Figure 2.9 Selected COSY and HMBC correlations establishing side chains off the aromatic ring 
in 86. 
A similar substructure is observed in fistularin-3 (86) previously reported in 1979.94  
Fistularin-3 is a bromo tyrosine derived metabolite which has been found to be a 
distinct marker for the marine sponges belonging to the order Verongida.95  
Compound 86 was previously isolated by Taufa in the marine natural products group at 
VUW from an unidentified Tongan sponge sample.32  The spectral data collected during 
Taufa’s study was compared to the data from this study with several similarities 
observed suggesting that the isolated compound in this study was fistularin-3.32 
 
Confirmation of the presence of fistularin-3 was achieved by elucidating the 
substructure at one end of the compound. From the molecular formula it was 
determined that C18H8O6N2Br4 remained, accounting for the previously assigned 
aromatic containing substructure.  Further analysis of the spectral data revealed key 
COSY and HMBC correlations, which established the substructure shown in Figure 2.10 
comprised of carbons C-1 through C-8 and C-19.  These correlations revealed a 
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substructure of fistularin-3 with an observed connection to the aromatic containing 
substructure, through an HMBC correlation from H-7a to the amide carbonyl C-9, 
further confirming its presence.  The presence of a second identical substructure at the 
other end of 86 was confirmed by molecular formula determination and further 
spectral analysis.  The molecular formula of the substructure, C9H4O3NBr2 (excluding 
position nine), indicated that the remaining mass of the compound contained the 
identical C9H4O3NBr2 formula.  The resonances and correlations of the second 
substructure were very similar to the first, as shown in Table 2.4.  The 1H NMR 
revealed shoulders on the peaks of H-1, H-5, H-7a and H-7b suggestive of signal 
overlap which confirmed the presence of two symmetrical substructures. 
 
Figure 2.10 COSY and HMBC correlations establishing the terminal substructures of 86. 
The appearance of fistularin-3, a common sponge secondary metabolite, in the algal 
sample suggested that the initial sample extracted may have contained a sponge 
contaminant.  Upon further investigation, it was confirmed that a small sample of an 
unidentified black sponge had contaminated the original extraction (see Figure 2.11).  
The sponge contaminant was approximately 2 x 1 cm, and weighed 0.22 g.  The 
appearance of fistularin-3 in the sample, given the mass of sponge compared to algae 
present, indicated that Tongan sponges contain much higher concentrations of 
secondary metabolites than their algae counterparts. 
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A second extraction of PTN3_38C was performed, ensuring there was no sponge 
contamination.  The screen spectra revealed several resonances in the oxymethine 
region, consistent with the commonly observed glyceroglycolipid, however, no 
aromatic resonances attributable to fistularin-3 were observed.  This confirmed that 
the sponge accounted for the interesting signals observed after the first extraction. 
 
Figure 2.11 Photos of the PTN3_38C algae sample extracted, with highlighted contaminant. 
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Table 2.4 13C (150 MHz) and 1H (600 MHz) NMR data (CD3OD) for fistularin-3 (86). 
 
 
 
 
 
 
 
 
 
 
 
 
13
C 
 
1
H COSY HMBC 
Position δ (ppm) mult 
 
δ (ppm) (
1
H-
1
H) (
1
H → 
13
C) 
1 75.3 CH 
 
4.09 5 2, 3, 4, 5, 6, 7, 19 
1' 75.2 CH 
 
4.09 5' 2', 3', 4', 5', 6', 7', 19' 
2 122.6 C 
    
2' 122.6 C 
    
3 149.1 C 
    
3' 149.1 C 
    
4 114.0 C 
    
4' 114.0 C 
    
5 132.1 CH 
 
6.42 1 1, 2, 3, 4, 6, 7 
5' 132.0 CH 
 
6.42 1' 1', 2', 3', 4', 6', 7' 
6 92.3 C 
    
6' 92.3 C 
    
7a 39.9 CH2  
3.79 7b 1, 2, 5, 6, 8, 9 
7b 
   
3.12 7a 1, 4, 5, 6, 8, 9 
7'a 39.9 CH2  
3.74 7'b 1', 2', 5', 6', 8' 
7'b 
   
3.08 7'a 1', 4', 5', 6', 8', 9' 
8 155.0 C 
    
8' 154.9 C 
    
9 161.6 C 
    
9' 161.5 C 
    
10a 43.6 CH2  
3.72 10b, 11 9, 11, 12 
10b 
   
3.50 10a, 11 9, 11, 12 
11 69.8 CH 
 
4.22 10a, 10b, 12a, 12b 10, 12 
12a 75.7 CH2  
4.04 11, 12b 10, 11, 13 
12b 
 
CH2  
3.99 11, 12a 10, 11, 13 
13 153.1 C 
    
14 118.7 C 
    
15 131.6 CH 
 
7.62 17 13, 14, 15, 16, 17 
16 143.1 C 
    
17 71.4 CH 
 
4.76 15, 18a, 18b 15, 16, 18 
18a 47.5 CH2  
3.49 17, 18b 9', 16, 17 
18b 
   
3.40 17, 18a 9', 16, 17 
19 60.2 CH3  
3.74 
 
3 
19' 60.2 CH3  
3.74 
 
3' 
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2.7. Summary 
This study of marine algae was conducted with a sample size of 11 algal specimens 
collected from various regions around the island of Vava’u, Tonga.  The study was 
undertaken to answer whether the structural diversity of secondary metabolites found 
in Tongan algae, compared with New Zealand algae, rivalled the concentration and 
increased structural diversity observed in Tongan sponges compared to New Zealand 
sponges.  The sample size of 11 algae was used to compare with the previous study of 
temperate red algae collected in New Zealand waters which had revealed the isolation 
of several novel oxylipins and a nitrogenous bromophenol compound along with other 
diverse known compounds.   
Although 11 specimens was a small sample size, the results from the screening spectra 
highlighted that the 75% Me2CO in H2O samples of Tongan algae exhibited lower 
concentrations of secondary metabolites across all samples, compared to temperate 
New Zealand red algae.  The structural diversity of Tongan algae appeared to be less 
diverse than that of New Zealand algae as there was a large presence of 
glyceroglycolipid and other fatty acid containing compounds.  The 6-amino-6-
deoxyglucose glyceroglycolipid isolated from PTN4_17G appeared to be present in 
green, red and brown algae samples, perhaps indicating it was a common tropical algal 
primary metabolite rather than a secondary metabolite. 
The results of this study suggested that the increase in concentrations and structural 
diversity of secondary metabolites isolated from tropical sponges, compared to 
temperate sponges is reversed in macro-algae.  The lower concentration of secondary 
metabolites was confirmed during isolation of fistularin-3, where a small sponge 
contaminant overshadowed a larger algae sample in the extract screen.  A larger 
sample size of tropical algae would be required to fully confirm the findings from this 
study.  No biological testing was performed during this study as full purification was 
not achieved. 
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Chapter 3  
 
Investigation of Marine Sponges 
3.1. Introduction 
Sponges, phylum Porifera, are considered to be the most primitive metazoans (multi-
cellular animals) with fossil evidence dating back to Cambrian times, approximately 
500 million years ago, providing evidence that sponges were widespread inhabitants of 
the ocean reefs.96  Sponges show few of the features ordinarily associated with 
commonly recognised animals, including the lack of a nervous, circulatory or digestive 
system meaning a low level of cellular organisation.97  The animal nature of sponges 
was therefore not recognised until the late 18th century due to their basic structure 
and primitive characteristics.97  However, for all their primitive characteristics, sponges 
account for a large proportion of the epifaunal biomass.  In 1994, there was a 
conservative estimate of 15,000 species of sponges worldwide which has since grown 
to in excess of 20,000 recorded species in 2012.98-99 
The taxonomy within Porifera is not certain and continues to be revisited as the 
physical and morphological characteristics, normally used to resolve species, are 
restricted.  A given sponge’s colour, size and shape can be affected by the environment 
in which the sponge is found.  Species are therefore primarily classified based on their 
skeletal framework (spicules).  Using spicule characterisation the phylum Porifera was 
originally divided into three classes:  Calcarea (sponges with a mineral skeleton 
composed entirely of calcium carbonate), Demospongiae (sponges with siliceous 
spicules and with a skeleton of organic fibres or fibrillar collagen) and Hexactinellida 
(sponges with siliceous spicules), shown in Table 3.1.100  Highlighted in red in Tables 3.1 
and 3.2, adapted from Hooper and van Soest99 is the taxonomic classification from the 
phylum porifera of the sponge species analysed in this study.   
Demospongiae is the largest and most diverse class of Porifera.  It is divided into 13 
orders, of which Poecilosclerida is one of the largest.  The order Poecilosclerida 
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contains several families of sponges, including Raspailiidae, which contains the genus 
Raspailia (Table 3.2).99 
 
 
 
Table 3.1 Taxonomic classification of the phylum porifera to the order level.99 
Phylum Class Sub-class Order 
Porifera 
Calcarea 
 
Baerida 
Calacaronea Leucosolenida 
 
Lithonida 
Calcinea 
Clathrinida 
Murrayonida 
Demospongiae 
Ceractinomorpha 
Agelasida 
Dendroceratida 
Dictyoceratida 
Halichondrida 
Halisarcida 
Haplosclerida 
Poecilosclerida 
Verongida 
Verticillitida 
Tetractinomorpha 
Astrophorida 
Chondrasida 
Hadromerida 
Spirophorida 
Homoscleromorpha Homosclerophida 
Hexactinellida 
Amphodiscophora Amphodiscosida 
Hexasterophora 
Aulocalycoida 
Hexactinosida 
Lychnicosida 
Lyssacinosida 
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Table 3.2 Taxonomic classification of the genus Raspailia from the order Poecilosclerida.99 
Order Sub-order Family Sub-family Genus 
Poecilosclerida 
Latrunculia Latrunculiidae … 
 
Microcionina 
Acarnidae … 
 
Microcionidae … 
 
Raspailiidae 
Cyamoninae 
Cyamon 
Trikentrion 
Waltherarndtia 
Echinodictyinae 
Amphinomia 
Echinodictyum 
Plocamioninae 
Lithoplocamia 
Plocamione 
Raspailiinae 
Aulospongis 
Ectyoplasia 
Endectyon 
Eurypon 
Hymeraphia 
Raspaciona 
Raspailia 
Rhabdeurypon 
Thrinacophorinae 
Axechina 
Ceratopsion 
Thrinacophora 
Rhabderemiidae … 
 
Mycalina 
Chladorhizidae … 
 
Desmacellidae … 
 
Esperiopsidae … 
 
Guitarridae … 
 
Hamacanthidae … 
 
Isodictyidae … 
 
Merliidae … 
 
Mycalidae … 
 
Podospongiidae … 
 
Myxillina 
Chondropsidae … 
 
Coelosphaeridae … 
 
Crambeidae … 
 
Crellidae … 
 
Dendoricellidae … 
 
Desmacididae … 
 
Hymedesmiidae … 
 
Iotrochotidae … 
 
Myxillidae … 
 
Phellodermidae … 
 
Tedaniidae … 
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3.2. Raspailia Species – A Chemical History 
The genus Raspailia is characterised by the absence of microscleres and contains more 
than 100 described species.  These species are distributed world-wide, mainly in 
shallow waters, and have been studied with some success due to the ease of 
accessibility.99  As of 2011, over forty different secondary metabolites have been 
reported from Raspailia sponges belonging to five main families of compounds: 
raspailynes, raspailols, asmarines, agminosides and clerodane diterpenes. 
The first reports of isolated secondary metabolites were from the sponges R. pumila 
and R. ramosa collected from the North-East Atlantic.  They were found to contain a 
series of novel long-chain enol ethers of glycerol.  The generic structure contains a 
conjugated system, made up of an enol ether, an acetylenic bond, and a 1,2-
disubstituted olefinic bond.101-102  The family of raspailynes was categorised by the 
configuration of the two double bonds in the compound.  Three such configurations 
have been found with the most common being the (1Z,5Z) configuration observed in 
raspailynes A, A1, B, B1, B2 (87-91) and isoraspailynes A, B and B1 (92-94).101-102  The 
(1Z,5E) configuration was observed in isoraspailyne Ba and B1a (95-96) with the final 
(1E,5Z) configuration, present in isoraspailyne B1b (97).102  There have been no reports 
of raspailynes containing an (1E,5E) configuration. 
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In the mid 1990s, two cyclic hemi-acetals, raspailol A and B (98-99), were isolated from 
an unknown Palauan Raspailia sponge species.103  The absolute configuration of the 
ring was determined by Mosher’s method, however, full stereochemical assignment 
was not obtained until total synthesis of raspailol A and B was achieved.104  At the 
time, the chemotaxonomy of 97-98 was unknown, however, they appeared to be a 
unique class of the polyketide family.     
Asmarines A–K (100-110) are a family of nitrogen-containing metabolites that were 
found to be of mixed biogenesis: clerodane diterpene and adenine.  The compounds 
were collected, each from unidentified Raspailia sponge species, from three separate 
locations.  Compounds 100–105 were collected from the Red Sea with 100 and 101 
showing micromolar cytotoxic activity against murine leukaemia, human lung 
carcinoma, human colon carcinoma and human melanoma cell lines.105-106  Compounds 
106–107 were collected from Wasini Island, off the coast of Kenya, while 108–110 
were collected from Nosy Be, an Island off the coast of Madagascar.107-108  Compounds 
102–110 still possessed some cytotoxicity but at levels less potent than 100 and 
101.106-108  Two new diterpenes, barekol (111)107 and nosyberkol (112)108 were also 
isolated along with three known diterpenes. 
In addition to the novel compounds isolated from Raspailia, there have been reported 
isolations of some known compounds of interest.  Esmodil (113), an acetylcholine 
mimetic, and phorboxazoles A and B (114-115), known antifungal and cytostatic 
macrolides, were isolated from an unknown Raspailia species off the coast of Western 
Australia.109  The isolation of 113 was of particular interest as it was a known synthetic 
drug that had been investigated during the 1930s.  The compound 1,4-dideoxy-1,4-
imino-D-arabinitol (116) was also isolated from an unknown Raspailia species from the 
coast of Western Australia.110  This compound was previously isolated from terrestrial 
plants and has since been synthetically produced as it possesses α-glucosidase 
inhibitory properties.110    
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The marine natural products group at VUW has investigated two New Zealand species 
of Raspailia with several novel compounds isolated in each case.  Raspailia agminata, 
collected from Taheke Reef in the Cavalli Islands, Northland, was found to contain the 
agminosides, a novel family of glycolipids.  Agminosides A-E (117-121) contained up to 
six partially acetylated glucose residues bound to the same length aglycon methyl 
ester.42,111  Despite their novel structures, the agminosides did not exhibit strong 
biological activity. 
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The New Zealand marine sponge Raspailia topsenti, (Dendy112), has also proven to be a 
rich source of secondary metabolites.  It has been studied in much detail affording 
numerous novel secondary metabolites.  Several collections have been made from 
different sites around New Zealand with the original source being from Doubtful 
Sound, Fiordland. 
From the first collection, the clerodane diterpenoids raspailol (122), raspailenone A 
(123) and raspailodanes C (124) and D (125) were isolated.36,113  Additional collections 
of R. topsenti have been made from at least four other locations around New Zealand 
– D’Urville Island, Marlborough Sounds; off the coast of New Plymouth; Three Kings 
Islands, north of Cape Reinga; and Elizabeth reef, Tutukaka, Northland.  Further work 
on R. topsenti collected from D’Urville Island and off the coast of New Plymouth 
resulted in the isolation of three further clerodanes, raspailodanes A (126), B (127) and 
E (128).38   
Investigation of the Three Kings Islands collection afforded the novel clerodanes 
topsentane A and B (129-130) and raspailenone B (131).114  This was followed by the 
isolation of the novel, raspailodane F and G (132-133) alongside (122) and (127).38  One 
final compound isolated by the VUW research group, was the β-substituted-γ-hydroxy-
butenolide analogue of 122, compound 134.115  Due to insufficient material the 
stereochemistry of 134 could not be assigned, however, it is most likely analogous to 
122.  It is important to acknowledge that the profile of compounds was different in 
each geographical variant.38  Biological testing was performed across the novel 
clerodanes isolated with 122 and 129-130 having shown to possess anti-inflammatory 
activity in vitro.36,114 
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3.3. PTN2_45D 
PTN2_45D, an orange-finger sponge (Figure 3.1) of the genus Raspailia was collected 
off Elizabeth reef, Tutukaka, Northland in November 2003.  This particular sponge was 
subjected to the standard HSQC screening protocol, however was not studied in any 
further detail.  Singh’s subsequent HMBC study highlighted prominent features in the 
screen, shown in Figure 3.2, which included correlations to functionalised carbons such 
as ketone, alkene and acetal centres.41  From the screen, characteristic clerodane 
diterpene correlations were observed that were consistent with compounds previously 
mentioned in this chapter.  However, Singh indicated that there were a number of 
correlations across the spectrum that were not associated with the furan and acetal 
regions of known clerodane diterpenes, therefore suggesting that the sponge sample 
warranted further investigation.  The sponge bore similarities to R. topsenti including 
the bright orange colour, however, the morphology was slightly different.  Figure 3.1 
illustrates the morphological differences observed between a known R. topsenti 
sample and the Raspailia sample that was investigated during this study. 
 
Figure 3.1(a) Surface image of PTN2_45D, analysed in this study. (b) Underwater photograph 
of Raspailia topsenti (photograph by Alan Duckworth). 
 
 
 
 
(a) (b) 
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Figure 3.2 HMBC screen of 75% Me2CO in H2O sample of PTN2_45D (CD3OD) performed by 
Singh.41 
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3.4. Isolation Procedure 
In this study, an extraction of 100 g of an unknown Raspailia sponge species collected 
from Elizabeth reef, Northland, was performed.  The sponge was extracted twice with 
MeOH and the extracts were cyclic loaded onto reversed-phase HP20 beads.  The 
column was then eluted with increasing concentrations of Me2CO in H2O.  Previous 
studies used eluting concentrations of 20, 40, 75, 85 Me2CO in H2O and 100 % 
Me2CO
36,38,114 whereas in this study the five eluting fractions 20, 40, 60, 80 Me2CO in 
H2O and 100% Me2CO were used.   
As mentioned previously, a number of clerodanes have been isolated from a known R. 
topsenti species, all possessing a β-substituted furan ring, which have diagnostic 
proton signals in the aromatic region (6-8 ppm) of a 1H NMR.  These allowed for early 
detection of samples containing possible clerodane compounds.  The 40, 60 and 80% 
samples from the initial HP20 separation all showed the presence of furan signals in 
their respective 1H NMR spectra.  With one additional stage of purification, the 80% 
sample bore the known raspailodane A (126).   
Early studies of R. topsenti, in the laboratory at VUW using 1D 1H NMR, suffered from 
the inability to easily detect functionality below 5 ppm, without purification, due to 
NMR signal overlap (outlined in Chapter 1).  Backed by a more sensitive instrument 
and a modified isolation protocol, interesting signals were observed in the oxymethine 
region (3-5 ppm) of the 60% and 80% fractions.  These oxymethine correlations 
combined with the presence of several sp3 carbon signals was suggestive of a saponin.  
These molecules are often large in size, and therefore size exclusion chromatography 
was employed using LH-20, a hydroxypropylated bead-formed dextran medium.  
Further purification involved the use of normal-phase chromatography (DIOL) and 
reversed-phase HPLC (C18).   
Full purification was made difficult as a minor compound presumed to be related, 
appeared to behave similarly during purification.  NMR studies suggested that the 
minor compound only differed in the side chain of the aglycon.  Scheme 3.1 shows the 
isolation procedure, where the sample is split in half with one half purified using HPLC 
and the other through repeated LH-20 columns with mixed solvent systems 
implemented to afford polar separations.  It was found through reversed-phase HPLC 
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that the aglycon moiety appeared to be purified (major: minor approximately 15:1) 
while purification of the polar sugar moiety was minimal.  Through repeated LH-20 
columns it was found that the polar sugar moiety was purified while purification of the 
non-polar moiety was not achieved as well as seen with HPLC.  Each pathway provided 
a sample that was found to be primarily the same single compound with differing 
impurities.  Spectral data from each purification pathway was used in elucidating the 
structure as full pure isolation of the major compound could not be unequivocally 
obtained (ratio 15:1).   The purification scheme led to the isolation and structural 
elucidation of the major compound raspailoside A (135), a novel steroidal glycoside. 
 
3.5. Raspailoside A 
The molecular formula of raspailoside A (135) was determined to be C51H83O20N from a 
positive ion mode HRESIMS measurement of the [M+H]+ pseudomolecular ion peak at 
m/z 1030.5573 (Δ -0.91 ppm).  The molecular formula indicated the presence of 11 
double bond equivalents in the molecule.  Detailed 1H NMR, COSY, HSQC and HMBC 
data was obtained for structural elucidation, however 13C NMR data obtained was 
weak and difficult to analyze and therefore not used during characterisation.  All 
carbon shifts were obtained from HSQC and HMBC spectra run.  From the HSQC 
experiment 46 carbons were confirmed to be present, consisting of six methyls, 10 
methylenes, four oxymethylenes, seven methines, 18 oxymethines and one 
aminomethine, accounting for 72 hydrogens.  The remaining five non-protonated 
carbons were observed through correlations in the HMBC to consist of two carbonyls 
(δC 174.2 and 217.9), one olefinic (δC 141.4) and two sp
3 quaternary centres (δC 37.5 
and 43.2).  HSQC correlations showed only one signal present in the olefinic region (δC 
122.5) indicating the presence of one double bond, which revealed that the compound 
was an octacyclic structure. 
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Scheme 3.1 The procedure leading to the isolation of raspailoside A (135) from PTN2_45D.
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Oligosaccharide Chain of 135 
Using a combination of COSY, HSQC, HMBC, HSQC-TOCSY, 1D TOCSY and ROESY 
experiments the structures of each monosaccharide unit was determined along with 
the relative stereochemistry in each unit. Additionally, the nature of the glycosidic 
linkages could be ascertained using these experiments.  
The HSQC experiment showed the presence of four anomeric methines S1-CH-1 (δC 
102.0, δH 4.47), S2-CH-1 (δC 103.5, δH 4.81), S3-CH-1 (δC 100.0, δH 4.63) and S4-CH-1 (δC 
104.7, δH 4.32), which, along with the large number of oxymethines present, indicated 
the presence of four sugar subunits.  Due to the presence of these similar subunits, the 
oxymethine region of the HSQC was quite complicated.  COSY spectra, which could 
normally be used to elucidate the structure of a sugar residue by following coupled 
proton shifts around the sugar ring, proved difficult to analyse due to severe signal 
overlap.  This overlap can lead to the unintentional combination of different sugar 
systems during structural elucidation.  The HSQC-TOCSY sequence was a very useful 
experiment in the identification of distinct sugar spin systems.  The experiment is an 
extension of the HSQC in which a TOCSY transfer between protons is added prior to 
data acquisition thus relaying the original proton-carbon correlation peak onto 
neighbouring protons within the same spin system, producing a 13C-dispersed TOCSY 
spectrum.116  The carbon dimension allowed for unambiguous assignment of 1H signals 
to each subunit.  This dispersion of the proton spin system in the carbon dimension, 
gave a distinct pattern of signals for each sugar ring.  The HSQC-TOCSY was used to 
separate the signals into four distinct spin systems relating to each sugar moiety, 
illustrated in Figure 3.3. 
The ROESY experiment (rotating frame NOE) was chosen to detect through space 
proximity, after weak correlations of varying phase were observed in 1D and 2D NOESY 
experiments.  The weak NOESY results are consistent with a molecule having a 
molecular mass of 1000-1500 atomic mass units (amu) where Z-axis or transient NOEs 
are weak and of alternate sign for molecules of this size.116  As stated, raspailoside A 
has a molecular mass of 1029.55 amu which fell in the range where NOESY 
experiments were less effective. 
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Figure 3.3 An HSQC-TOCSY spectrum with the four distinct sugar spin systems. Green for sugar 
one, blue for sugar two, black for sugar three and red for sugar four. 
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Sugar One 
Figure 3.3 revealed a spin system (shown in green) that was comprised of one 
anomeric (acetal) (CH-1 δC 102.0, δH 4.47), three oxymethines (CH-2 δC 73.2, δH 3.39, 
CH-3 δC 79.4, δH 3.78, CH-4 δC 74.9, δH 3.86) and one oxymethylene (CH2-5 δC 62.4, δHa 
3.98, δHb 3.30). 
A series of COSY correlations that were observed (H-1 to H-2, H-2 to H-3, H-3 to H-4,  
H-4 to H-5a, H-4 to H-5b and H-5a to H-5b), revealed a linear carbon chain typical of a 
sugar moiety, represented in Figure 3.4.  The sequence of oxymethines in the sugar 
ring was confirmed using 1D TOCSY experiments.  By selectively exciting the anomeric 
proton, and then progressively increasing the spin lock mixing time, from 15 to 150 ms 
in 15 ms increments (each increment providing a separate FID), excitation is 
progressively transferred to other neighbouring spins exciting the protons providing 
spectral signals.  As the mixing time increased, the signals further from the anomeric 
centre were revealed in the order observed from the COSY data.  Proton H-2 was 
revealed at 30 ms, H-3 at 45 ms, H-4 at 75 ms, until the methylene protons H-5a and  
H-5b were revealed at a mixing time of 105 ms.  A second 1D TOCSY experiment was 
performed by selectively exciting proton H-5a under the same conditions.  The protons 
were revealed in the correct reverse order, beginning with proton H-5b at 15 ms and 
ending with proton H-1 at 90 ms.  Both 1D TOCSY experiments are illustrated in Figure 
3.4. 
 
Figure 3.4 COSY and 1D TOCSY data establishing the connectivity of the carbon chain in sugar 
one. 
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HMBC correlations were observed from H-1 to C-5 and H-5a,b to C-1, as shown in 
Figure 3.5.  This revealed an ether linkage from C-1 to C-5 which established a pyrano-
pentose ring system.  Further HMBC correlations were observed, including H-2 to C-1, 
H-2 to C-3, H-3 to C-2, H-3 to H-4, and between H-5a and C-3, all consistent with the 
established sequence. 
 
Figure 3.5 Selected HMBC correlations establishing the cyclic ring connectivity of sugar one. 
The relative stereochemistry of the protons around the ring was established by using a 
combination of 1H-1H coupling constants, observed in 1H NMR and 1D TOCSY 
experiments, and through space NOE correlations (observed via a series of 1D ROESY 
experiments).  From the 1H NMR, H-1 was observed to be doublet with a coupling 
constant of 6.2 Hz.  The large coupling constant indicated a 1,2-trans diaxial 
relationship between H-1 and H-2, establishing a β configuration at the C-1 position (H-
1 axial, β face) and H-2 axial, on the α face of the ring system.  From the 1D TOCSY 
experiment, the multiplicities of all the protons in the spin system were clearly 
resolved and the coupling constants could be determined for protons H-2, H-3, H-4, H-
5a and H-5b.  Proton H-2 was observed to be a triplet with a coupling constant of 6.8 
Hz which indicated a 1,2-trans diaxial relationship with H-3, confirming the H-2 
assignment and, indicating that H-3 was axial on the β face.  Proton H-3 was revealed 
to be a triplet with a coupling constant of 7.7 Hz which indicated a 1,2-trans diaxial 
relationship with H-4, confirming the H-3 assignment while indicating that H-4 was 
axial on the α face.  Proton H-4 was observed to be a multiplet and therefore coupling 
constants to protons H-5a and H-5b could not be determined.  Protons H-5a and H-5b 
were clearly observed as doublet of doublets in the 1H NMR and 1D TOCSY.  The 
coupling constant between H-5a and H-4 was observed to be 4.3 Hz whereas between 
H-5b and H-4 a larger coupling of 8.5 Hz was observed.  The coupling indicated there 
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was a 1,2-trans diaxial relationship between H-5b and H-4, which suggested H-5b was 
axial on the β face of the ring while H-5a was equatorial on the α face.  Given the 
coupling and multiplicity that was observed it was determined that sugar one was a β-
xylopyranose subunit, illustrated in Figure 3.6.    
The proposed relative stereochemistry was confirmed by relevant cross peaks seen in 
ROESY experiments.  NOE correlations between H-1 and H-3 (seen both from H-1 to H-
3 and H-3 to H-1) and also from H-1 to H-5b indicated 1,3-diaxial relationships.  This 
confirmed that H-1, H-3 and H-5b were all on the same face of the ring, shown in 
Figure 3.6.  An NOE correlation was also observed from H-5a to H-4 which confirmed 
that they were on the same face of the ring.  Given the confirmed sequence of 
carbons, the oxacyclic ring structure and the stereochemical relationship of the 
protons around the ring, the data was consistent with a β-xylopyranose structure. 
 
Figure 3.6 NOE correlations and large 1,2-diaxial vicinal coupling establishing the relative 
stereochemistry of sugar one. 
Sugar Two 
Full characterisation of sugar two was provided although it bore close resemblance to 
the previously elucidated sugar one.  The HSQC-TOCSY experiment revealed a spin 
system (shown in blue in Figure 3.3) that was comprised of one anomeric (acetal) (CH-
1 δC 103.5, δH 4.81), three oxymethines (CH-2 δC 73.5, δH 3.36, CH-3 δC 75.1, δH 3.45, 
CH-4 δC 70.6, δH 3.53) and one oxymethylene (CH2-5 δC 65.5, δHa 4.09, δHb 3.34). 
A series of COSY correlations observed (H-1 to H-2, H-2 to H-3, H-3 to H-4, H-4 to H-5a, 
H-4 to H-5b and H-5a to H-5b), revealed a linear carbon chain typical of a sugar moiety, 
identical to sugar one, shown in Figure 3.7.  The sequence of oxymethines in the chain 
was confirmed using 1D TOCSY experiments, illustrated in Figure 3.7.  Selective 
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excitation of the anomeric proton H-1 was performed, with the progressive increase in 
the spin lock mixing time revealing the proton shifts in the order observed from the 
COSY data.  Similarly, the correct reverse order was observed in a 1D TOCSY series 
where H-5a was irradiated.  
 
Figure 3.7 COSY and 1D TOCSY data establishing the carbon chain connectivity in sugar two. 
HMBC correlations were observed from H-1 to C-5, H-5a to C-1 and H-5b to C-1, shown 
in Figure 3.8.  This revealed an ether linkage from C-1 to C-5 which established a 
second pyrano-pentose ring system. 
 
Figure 3.8 Selected HMBC correlations establishing the cyclic ring connectivity of sugar two. 
The relative stereochemistry of the protons around the ring of sugar two was 
established by using a combination of 1H-1H coupling constants and through space NOE 
correlations.  From the 1H NMR, H-1 was observed to be a doublet with a coupling 
constant of 6.1 Hz.  The large coupling constant indicated a 1,2-trans diaxial 
relationship between H-1 and H-2 and established a β configuration of the C-1 position 
(H-1 axial, β face) and assigning H-2 axial, on the α face of the ring system.  From the 
1D TOCSY experiment, the multiplicities of the protons were clearly resolved and the 
coupling constants were determined for protons H-2 (t, 6.8 Hz), H-3 (t, 7.5 Hz), H-4 
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(multiplet), H-5a (dd, 11.8, 4.5 Hz to H-4) and H-5b (dd, 12.0, 8.2 Hz to H-4).  The large 
coupling constants observed in sugar two were similar to those observed in sugar one, 
therefore indicating the axial positions of the methine protons, shown in Figure 3.9.  
These similarities led to the assignment of sugar two as a second β-xylopyranose ring 
system.  
The proposed relative stereochemistry was confirmed by relevant NOE correlations 
seen in ROESY experiments, also shown in Figure 3.9.  NOE correlations between H-1 
and H-3, and H-1 and H-5b indicated the presence of 1,3-diaxial relationships.  This 
confirmed that H-1, H-3 and H-5b were all on the same face of the ring.  An NOE 
correlation was also observed from H-5a to H-4 which confirmed that they were on the 
same face of the ring.  Given the confirmed sequence of carbons, the oxacyclic ring 
structure and the stereochemical relationship of the protons around the ring the data 
was consistent with an established β-xylopyranose structure. 
 
Figure 3.9 NOE correlations and large 1,2-diaxial vicinal coupling establishing the relative 
stereochemistry of sugar two. 
Sugar three 
From the HSQC-TOCSY experiment a third spin system was observed, shown in black in 
Figure 3.3, that was comprised of one anomeric (acetal) (CH-1 δC 100.0, δH 4.63), one 
aminomethine (CH-2 δC 56.1, δH 3.71), three oxymethines (CH-3 δC 84.5, δH 3.67, CH-4 
δC 69.8, δH 3.45, CH-5 δC 77.4, δH 3.32) and one oxymethylene (CH2-6 δC 62.1, δHa 3.87, 
δHb 3.71).  An unusual upfield heteromethine was observed at δC 56.1 and δH 3.71 with 
a 1JCH value of 142 Hz, which was determined to be consistent with a nitrogen bound 
functionality, typically either an amino or amido group.  Correlations were observed in 
the HMBC between a methyl (δC 22.8, δH 1.98) and a carbonyl carbon (δC 174.2) and 
from H-2 to the carbonyl carbon.  The carbon shift of δC 174.2 is consistent with an 
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amido carbonyl carbon which suggested that the nitrogen group was a NHAc group, 
attached at position two, shown in Figure 3.10. 
In the previously described sugar subunits, COSY correlations were clearly discernible 
around the linear chain.  In sugar three however, the 1H resonances of H-2 and H-6b 
(δH 3.71 and 3.71) overlapped each other, while H-3 was also in close spectral 
proximity (δH 3.67), made analysis of the COSY spectra difficult.  Close examination of a 
double quantum filtered (DQF) COSY experiment provided evidence of H-2 to H-3, H-3 
to H-4, H4 to H-5, H-5 to H-6a, H-5 to H-6b and H-6a to H-6b correlations which 
established a linear chain from C1 through to C6, illustrated in Figure 3.10.  
A series of 1D TOCSY experiments, with selective excitation of the anomeric centre H-1 
and progressive spin lock mixing times, afforded information confirming the sequence 
of the chain, shown in Figure 3.10.  At 30 ms both H-2 and H-3 were revealed, proton 
H-4 was observed at 45 ms, H-5 at 75 ms and H-6a at 120 ms.  Proton H-6b could not 
be easily revealed during the 1D TOCSY experiment due to overlap with H-2, however a 
shoulder was seen on the original H-2 triplet peaks which may indicate the presence of 
H-6b after 120 ms.  The HMBC experiment showed correlations that confirmed the 
established carbon chain sequence.  The correlations observed were from H-2 to C-1 
and C-3; H-3 to C-1, C-2, C-4 and C-5; H-4 to C-3 and C-5; H-5 to C-6; H-6a to C-1 and C-
4 and H-6b to C-1 and C-5. The HMBC experiment did not reveal any correlations 
between positions CH-1 and CH-5 that indicated an ether linked sugar ring. 
 
Figure 3.10 DQF COSY and 1D TOCSY data establishing the carbon chain connectivity of sugar 
three. 
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Again, the relative stereochemistry of sugar three was determined using 1H-1H 
coupling constants, multiplicity and 1D NOE correlations.  H-1 was observed in a 
doublet environment with a coupling constant of 7.8 Hz.  The large coupling constant 
indicated a 1,2-trans diaxial relationship between CH-1 and CH-2, which established a 
β configuration of the anomeric position (H-1 axial, β face) and H-2’s position, axial on 
the α face.  The series of 1D TOCSY experiments from H-1, described earlier, clearly 
resolved H-2, H-3, H-4 and H-6a from the overall proton spectrum.  Proton H-2 was 
seen to be a triplet with a large coupling constant of 9.5 Hz which indicated a diaxial 
relationship with H-3, confirming the assignment of H-2, and indicating that H-3 was 
axial on the β face.  Proton H-3 was revealed as a triplet with a large coupling constant 
of 9.2 Hz which suggested a diaxial relationship with H-4, reaffirming the H-3 
assignment, while H-4 was established as axial on the α face.  Proton H-4 was observed 
to be a triplet with a large coupling constant of 8.9 Hz which indicated a diaxial 
relationship with H-5, supporting the assignment of H-4, and indicating that H-5 was 
axial on the β face.  Proton H-6a was revealed as being a doublet of doublets with a 
small coupling of 2.1 Hz to H-5 which suggested H-6a was equatorial to the ring.  
Proton H-6b was shielded by signal overlap and therefore multiplicity and coupling 
could not be determined.  Irradiation of H-1 in a 1D ROESY experiment revealed an 
NOE correlation between H-1 and H-3 indicating a 1,3-cis diaxial relationship.  The 
large couplings, NOE and established axial positions of protons H-1, H-2, H-3, H-4 and 
H-5 are consistent with a glucose configuration of a pyranohexose subunit, illustrated 
in Figure 3.11.  This established the structure of the subunit as 2-(acetylamino)-2-
deoxy-D-glucose or N-acetylglucosamine. 
 
Figure 3.11 An NOE correlation and large 1,2-diaxial vicinal coupling establishing the relative 
stereochemistry of sugar three. 
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Sugar Four 
The fourth sugar-like spin system from the HSQC-TOCSY experiment, shown in red in 
Figure 3.3, was comprised of the remaining one anomeric (acetal) (CH-1 δC 104.7, δH 
4.32), four oxymethines (CH-2 δC 74.5, δH 3.22, CH-3 δC 77.4, δH 3.34, CH-4 δC 71.1, δH 
3.29, CH-5 δC 77.9, δH 3.30) and one oxymethylene (CH2-6 δC 62.2, δHa 3.87, δHb 3.63). 
The spectral data of sugar four was difficult to analyse as the overlap of signals in the 
subunit (H-3, H-4 and H-5 separated by 0.05 ppm) were more severe than in the case 
of sugar three.  COSY correlations were observed from H-1 to H-2, H-2 to H-3 and H-6a 
to H-6b.  COSY correlations were also observed from H-3, H-6a and H-6b into an 
unresolved proton environment at approximately δH 3.30, illustrated in Figure 3.12.  A 
series of 1D TOCSY experiments, selectively exciting the anomeric centre H-1 and then 
progressively increasing the spin lock mixing time provided evidence of a contiguous 
system from H-1 through to H-6a and H-6b which indicated that there was two 
oxymethines present, in the unresolved section of the chain, shown in Figure 3.12.  
HMBC correlations within sugar four were only useful in reaffirming positions H-1, H-2 
and H-3.  Although correlations confirming the sugar ring system were not observed in 
the HMBC experiment the resonances from the spectra analysed (1H, COSY, HSQC, 
HMBC, 1D TOCSY and 1D ROESY) were diagnostic of a sugar moiety. 
 
Figure 3.12 COSY and 1D TOCSY data establishing the carbon chain connectivity of sugar four. 
The relative stereochemistry of sugar four was determined using 1H-1H coupling 
constants, multiplicity and 1D NOE correlations.  H-1 was observed in a doublet 
environment with a coupling constant of 7.8 Hz.  The large coupling constant indicated 
a 1,2-trans diaxial relationship between H-1 and H-2, which established a β 
configuration of the anomeric position (H-1 axial, β face) and H-2’s position, axial on 
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the α face.  Protons H-2 and H-3 were observed to be triplets with large coupling 
constants similar to sugar three, indicating similar proton stereochemistry (H-2, 8.5 Hz, 
axial, α face) and (H-3, 8.6 Hz, axial, β face).  The large coupling constant of H-3 
revealed that proton H-4 was in a 1,2-trans diaxial relationship with H-3, in an axial 
position on the α face.  Proton H-6a (dd, 11.9, 1.9 Hz) and H-6b (dd, 11.9, 5.9 Hz) 
possessed small and large coupling constants to H-5 respectively which indicated that 
H-6a was equatorial to H-5 and H-6b was axial.  This suggested that H-5 was in an axial 
position on the β face of the ring.  Irradiation of H-1 in a 1D ROESY experiment 
revealed NOE correlations from H-1 to H-3 and H-1 to H-5 indicating 1,3-cis diaxial 
relationships which suggested a glucose stereochemistry of the sugar moiety, 
illustrated in Figure 3.13.  
 
Figure 3.13 NOE correlations and large 1,2-diaxial vicinal coupling establishing the relative 
stereochemistry of sugar four. 
Full positional assignment was performed by comparing the 13C shifts of positions four 
and five to literature sources of glucose NMR, acquired in MeOD.111,117-120  Sources 
showed that the lower carbon shift is assigned position four of the ring (δC 71.1) and 
the higher shift, position five (δC 77.9).  Comparison of the carbon shifts of glucose 
with that of sugar four confirmed the NOE correlations observed, therefore sugar four 
was a β-D-glucopyranose moiety. 
 
Oligosaccharide Chain Connectivity 
The glycosidic linkages between the four sugar subunits and to the aglycon moiety 
were established through HMBC and NOE correlations.  All linkages were determined 
to be β-glycosidic linkages as the anomeric proton doublets possessed large coupling 
constants as mentioned previously.  Additionally, 1JCH coupling constants of 
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approximately 160 Hz were observed which support the axial positioning of the 
anomeric protons (a β 1JCH coupling constant is approximately 170 Hz).
121  The HMBC 
experiment revealed a correlation between S1-H1 and the oxymethine carbon of the 
aglycon, the only oxymethine unaccounted for by the four sugars.  This three-bond 
correlation firmly established a glycosidic linkage between S1 and the aglycon.  This 
linkage was confirmed by reciprocal NOE correlations observed between S1-H1 and 
the oxymethine proton of the aglycon.  An HMBC correlation was observed from S2-H1 
to S1-C3 which indicated that S2 was linked to S1 through a 1→3 glycosidic linkage.  
This three-bond correlation was confirmed by reciprocal NOE correlations between S2-
H1 and S1-H3.  HMBC correlations from S3-H1 to S1-C4 and S1-H4 to S3-C1 revealed a 
1→4 glycosidic linkage between S1 and S3.  The 1→4 linkage was confirmed by an NOE 
correlation observed from S3-H1 to S1-H4 which established a branched 
oligosaccharide chain.  Reciprocal HMBC correlations observed from S4-H1 to S3-C3 
and S3-H3 to S4-C1 revealed a 1→3 linkage between S4 and S3, confirmed by an NOE 
between the centres.  Additionally, the oxymethine centres were determined to be 
hydroxyl groups as all relevant proton and carbon shifts were consistent with this 
functionality.  Therefore the oligosaccharide chain was described as β-D-Glcp-(1→3)-β-
D-GlcpNHAc-(1→4)-[β-D-Xylp-(1→3)]-β-D-Xylp, shown in Figure 3.14. 
 
Figure 3.14 NOE and HMBC correlations establishing the oligosaccharide chain connectivity of 
135. 
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The Aglycon 
The oligosaccharide chain accounts for 25 carbons, 40 hydrogens, 19 oxygens and one 
nitrogen from the original formula C51H83O20N.  This indicated that the aglycon 
contained 27 carbons, 43 hydrogens and one oxygen atom.  The 27 carbons left 
included an oxymethine, a saturated ketone carbonyl, a tri-substituted double bond, 
and two quaternary centres while the 1H revealed two clearly discernible methyl 
singlets and a methyl doublet.  The oligosaccharide chain accounted for five double 
bond equivalents therefore six double bond equivalents were present in the aglycon 
structure.  This indicated that the aglycon was tetracyclic as four double bond 
equivalents remained after accounting for the ketone and double bond functionality.  
Using COSY, HSQC, HMBC and 1D TOCSY experiments, five proton spin systems were 
fully identified, which led to five substructure determinations accounting for most of 
the non-oxygenated carbons of the aglycon.  Full assembly of the aglycon was then 
achieved by COSY and HMBC correlations observed between the sub-structures. 
 
Substructure One 
A methylene (CH2-4, δC 39.3, δHa 2.40, δHb 2.24) was easily discernible in HSQC and 
COSY experiments.  A series of COSY correlations were observed from CH2-4 to an 
oxymethine CH-3 (δC 79.6, δH 3.49), from CH-3 to methylene CH2-2 (δC 30.5, δHa 1.87, 
δHb 1.60) and from CH2-2 to another methylene CH2-1 (δC 38.3, δHa 1.88, δHb 1.07).  
These 1H-1H couplings established the order of the carbon linkages and revealed a 
linear carbon chain C1-C2-C3-C4.  The order of this chain was confirmed by a series of 
1D TOCSY experiments, selectively exciting H-4a and H-4b, in separate experiments, 
observing through the increase in spin lock mixing time, first, the geminal partner 
followed by H-3, H-2a,b and finally H-1a,b.  HMBC correlations observed from H-4a to 
C-2 and C-3 and from H-1a,b to C-2 confirmed the established structure, illustrated in 
Figure 3.15.  The observed 13C and 1H shifts of CH-3 were consistent with an 
oxymethine position, which was identified previously as the attachment point for the 
oligosaccharide chain to the aglycon moiety. 
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Figure 3.15 Selected COSY and HMBC correlations establishing the connectivity of substructure 
one. 
 
Substructure Two 
Analysis of the HSQC data for 135 revealed a single downfield methine proton CH-6 (δC 
122.5, δH 5.38), indicative of an olefinic methine.  A bond was established between C-6 
and a slightly downfield methylene CH2-7 (δC 32.7, δHa 1.99, δHb 1.53), through 
observed COSY correlations from H-6 to H-7a,b.  A COSY correlation was then revealed 
from CH-7a to a methine proton, CH-8 (δC 32.9, δH 1.49), while the COSY correlation 
from H-7b to CH-8 was not clearly observed due to overlap of the two signals in the 
COSY spectrum.  The correlation between H-7a and H-8 confirmed a C7-C8 bond.  A 
COSY correlation was then observed between CH-8 and a second methine CH-9 (δC 
51.4, δH 0.95).  From this methine, a single COSY correlation was observed to 
methylene CH2-11 (δC 21.8, δH 1.54, 2H).  A single correlation was observed as the 
HSQC showed the methylene’s two proton resonances overlapped at 1.54 ppm.  A final 
COSY correlation was observed in this substructure from 11a,b to the methylene CH2-
12a,b (δC 40.8, δHa 2.04, δHb 1.20), which established the carbon connectivity illustrated 
in Figure 3.16. 
A series of 1D TOCSY experiments were performed starting from different signals along 
the substructure.  Selectively exciting H-6 resulted in the progressive appearance of 
protons H-7a,b, H-8 and H-9 (weakly) as the spin lock mixing time was increased.  
Selective excitation of H-9 revealed protons H-11a,b, followed by H-12a,b as the mixing 
time increased.  Protons H-8 through to H-6 were also observed with excitation of H-9 
which reaffirmed the carbon sequence in the substructure.  Additionally, along the 
substructure chain HMBC correlations were observed which confirmed the assignment 
of the sequence, shown in Figure 3.16. 
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Figure 3.16 Selected COSY and HMBC correlations establishing the connectivity of substructure 
two. 
 
Substructure Three 
Further analysis of the HSQC experiment revealed a methine proton CH-17 (δC 57.1, δH 
1.13) that was distinctive due to its downfield carbon shift.  A COSY correlation 
observed from H-17 to the methylene CH2-16 (δC 28.9, δHa 1.88, δHb 1.34) established a 
C-17 to C-16 bond.  COSY correlations were observed from H-16a,b to a second 
methylene CH2-15 (δC 25.0, δHa 1.63, δHb 1.12) which revealed a bond between C-16 
and C-15.  COSY correlations were then observed from H-15a,b to CH-14 (δC 57.8, δH 
1.03) a methine group with a similar downfield 13C NMR shift as C-17, which indicated 
that C-17 and C-14 were in similar environments.  Substructure three was confirmed as 
a C17-C16-C15-C14 carbon chain by a series of HMBC correlations as illustrated in 
Figure 3.17. 
 
Figure 3.17 Selected COSY and HMBC correlations establishing the connectivity of substructure 
three. 
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Substructure Four 
A deshielded methylene group CH2-23 (δC 38.0, δHa 2.54, δHb 2.46) was clearly observed 
in the HSQC spectrum.  COSY correlations observed from H-23a,b to methylene CH2-22 
(δC 30.7, δHa 1.73, δHb 1.23) revealed a bond between C-23 and C-22.  COSY 
correlations observed from H-22a,b to a methine, CH-20 (δC 36.4, δH 1.42), established 
a C-22 to C-20 bond.  COSY correlations between H-20 and methyl CH3-21 (δC 18.7, δH 
0.95) then revealed a bond between C-20 and C-21 off one branch of the C-20 
methine, which established the connectivity of substructure four, shown in Figure 
3.18.   
A series of 1D TOCSY experiments were run selectively exciting H-23a and H-21 and 
then increasing the spin lock mixing time to observe the neighbouring protons.  
Exciting H-23a saw the progressive excitation of H-23b followed by H-22a,b, H-20 and 
finally H-21 while excitation of H-21 first resulted in the appearance of H-20, followed 
by H-22a,b followed by 23a,b.  The 1D TOCSY data confirmed the order that was 
observed from the COSY data which established the substructure as the linear chain 
C23-C22-C20-C21.  Additionally, HMBC correlations confirming the substructure were 
observed, illustrated in Figure 3.18. 
 
Figure 3.18 COSY and HMBC correlations establishing the connectivity of substructure four. 
 
Substructure Five 
Analysis of the 1H NMR and HSQC revealed a deshielded septet methine, CH-25 (δC 
41.6, δH 2.68), that was clearly resolved in both spectra.  The septet environment of H-
25, together with only one observed COSY correlation suggested that C-25 was the 
central carbon in a spin system made up of an isolated isopropyl group terminus.  A 
COSY correlation observed from H-25 to methyls CH3-26 (δC 18.4, δH 1.07) and CH3-27 
(δC 18.4, δH 1.07), established bonds between C25-C26 and C25-C27.  HMBC 
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correlations, shown in Figure 3.19, were observed which confirmed the isolated 
isopropyl structure of substructure five. 
 
Figure 3.19 COSY and HMBC correlations establishing the connectivity of substructure five. 
 
Aglycon Substructure Connectivity 
Two methyl singlet carbons, one ketone carbonyl, one tri-substituted olefinic carbon 
and two quaternary carbon centres were unaccounted for after the elucidation of the 
five spin systems of the aglycon.  In the HMBC experiment, correlations were observed 
from the olefinic methine H-6 to the tri-substituted olefinic carbon C-5 (δC 141.4) 
establishing the C5-C6 double bond.  The deshielded protons H-4a,b revealed HMBC 
correlations to C-5 and C-6 which indicated a C-4 to C-5 bond, which established a 
connection between substructures one and two.  This connection was further 
confirmed by an HMBC correlation from H-6 to C-4 and the appearance of H-6 in the 
1D TOCSY experiments off H-4a,b.  Selected HMBC correlations are shown in Figure 
3.20.  A methyl singlet CH3-19 (δC 19.5, δH 1.03) displayed HMBC correlations to C-1, C-
5, C-9 and a quaternary centre C-10 (δC 37.5), as shown in Figure 3.20.  The HMBC 
correlations from the methyl singlet established the connection of C-19 to the 
quaternary centre C-10 and C-10 to C-1, C-5 and C-9.  HMBC correlations were also 
observed from H-1a to C-10 and C-19, from H-1b to C-9 and C-10 and also from H-9 to 
C-19.  This connectivity revealed the six-membered rings, A and B, fused at C-5 and C-
10, as shown in Figure 3.20.   
A third connection point amongst the aglycon substructures was determined using 
COSY and HMBC correlations.  A COSY correlation observed from H-8 to H-14 
established a single bond linkage between C-8 and C-14 the methine terminus of 
substructure three.  This linkage was confirmed by 1D TOCSY experiments with 
selective excitation of H-7a and H-9, in separate experiments, affording the 
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appearance of protons H-8 and H-14 as the mixing time was increased.  HMBC 
correlations, illustrated in Figure 3.20, reaffirmed the bond between C-8 and C-14. 
The second methyl singlet CH3-18 (δC 12.0, δH 0.72) correlated to carbons C-12, C-14, 
C-17 and the quaternary centre C-13 (δC 43.2) in the HMBC experiment, shown in 
Figure 3.20.  These correlations established the connection of C-18 to the quaternary 
centre C-13 and C-13 to C-12, C-14 and C-17.  HMBC correlations were also observed 
from H-12a to C-13 and C-14, H-12b to C-13, C-17 and C-19 and also from H-17 to C-12, 
C-13 and C-18, confirming this assignment.  These bonds established two additional 
rings in the aglycon structure, ring C, a cyclohexane ring, and ring D, a cyclopentane 
ring, as shown in Figure 3.20. 
 
Figure 3.20 Selected COSY and HMBC correlations establishing the connectivity of 
substructures one, two and three. 
Substructures one, two and three connected to form a tetracyclic backbone accounting 
for five double bond equivalents.  The remaining double bond equivalent was 
therefore a ketone present in the side chain.  A COSY correlation was observed from H-
20 to H-17, which established a C20-C17 bond, the side chain attachment point.  HMBC 
correlations revealed from H-17 to C-20, C-22, C-21, and from H-21 to C-17 confirmed 
the connectivity, shown in Figure 3.21.  Additional 1D TOCSY data, with selective 
excitation of H-21 revealed H-17 appearing in the spectra upon the increasing of the 
spin lock mixing time. 
The HMBC spectrum revealed the presence of a ketone carbonyl C-24 (δC 217.9) in the 
structure.  HMBC correlations observed from H-25,H-26, H-27, H-23a,b and H-22a,b to 
C-24, established the presence of the ketone between substructures four and five.  
Protons H-25 and H-23a,b were observed at higher shifts which were consistent with 
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the deshielding effects of the ketone functional group.  The data established 
connectivity between the substructures through C23-C24 and C24-C25 bonds.  This 
connectivity is shown Figure 3.21. 
 
Figure 3.21 Selected COSY and HMBC correlations establishing the connectivity of the side 
chain (substructures four and five) to the tetracyclic ring system of the aglycon. 
 
Relative Stereochemistry of the Aglycon 
Full stereochemical assignment of the aglycon could not be achieved from correlations 
alone, however, portions of the aglycon moiety could be assigned using a combination 
of 1H-1H vicinal coupling constants and NOE correlations from 1D ROESY experiments.  
It was important to ascertain the relative stereochemistry of centres C-3, C-8, C-9, C-
10, C-13, C-14 and C-17, as these positions had a large effect on whether the aglycon 
structure was planar in geometry or not, with Figure 3.22 illustrating the NOE 
correlations observed that aided in assigning these positions.   
A 1D ROESY experiment, with selective irradiation of H-3, showed NOE correlations 
from H-3 to S1-H1 which indicated that the oligosaccharide chain was linked through 
the equatorial position on C-3 and H-3 was therefore bound in the axial position, as 
drawn in Figure 3.22.  Protons H-4a,b were each subjected to 1D ROESY experiments 
to determine the stereochemistry at C-10.  Proton H-4a showed NOE correlations to H-
3 and S1-H1, which indicated that H-4a was on the same face of the ring as H-3, 
therefore equatorial (down).  This was confirmed as H-4b was observed in the 1D 
ROESY to be a broad triplet with a coupling constant of 12 Hz which indicated large 
geminal coupling with H-4a and large 1,2-diaxial coupling with H-3 therefore H-4b was 
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assigned axially on the top face of ring A.  An NOE correlation observed from H-4b to 
H-19 indicated that the methyl group at position C-10 was axial on the top face of ring 
A, as drawn. 
The stereochemistry of proton CH-9 was determined by using a combination of 1D 
ROESY experiments at H-3 and H-9.  An NOE correlation from H-3 to proton H-1b (δH 
1.07) indicated that H-1b was axial to the ring on the bottom face as illustrated in 
Figure 3.22.  An NOE correlation was also observed from H-9 to H-1b which confirmed 
that H-9 was also axial on the bottom face of the aglycon structure. 
The relative stereochemistry of C-13 and C-17 was determined by a 1D ROESY 
experiment irradiating the methyl at C-18.  An NOE correlation was observed from H-
18 to H-20, which indicated that methyl C-18 and side chain C-20 to C-27 were on the 
same face of the structure.  A 1D ROESY experiment was performed irradiating a 
proton shift of δH 0.95 which included H-9 and the methyl group, H-21.  NOE 
correlations were observed from δH 0.95 to H-12a,b which afforded the possible 
stereochemical assignment of H-18 and H-20 either the top or bottom face (as drawn).   
The axial and equatorial positions of C-12 were assigned on the proton shifts of H-12a 
and H-12b with the more deshielded signal H-12a (δH 2.04) designated equatorial on 
the top face and H-12b (δH 1.20) axial on the bottom face (as drawn).  A strong NOE 
correlation from H-21 to H-12a suggested that H-18 and H-20 were on the top face, as 
drawn.  The methyl group C18 was assigned axial off C-13, and C-20 was therefore 
assigned to be in an equatorial-like position (there is no true equatorial position on a 
five-membered ring).  This assignment was not unequivocal due to the signal overlap 
of H-9 and H-21, and the rotation that is possible with the side chain and CH3-21 group.  
A weak NOE correlation observed from H-18 to H-12a provides support for this 
assignment. 
A 1D ROESY experiment, irradiating the methyl H-18, revealed correlations that 
afforded additional stereochemical assignment around ring C.  An NOE correlation was 
observed from H-18 to H-8 which indicated that H-8 was axial on the top face of the 
structure.  This indicated that rings B and C were trans-fused. 
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Figure 3.22 Selected NOE correlations establishing the relative stereochemistry of the aglycon 
moiety in 135. 
The relative stereochemistry of C-14 could not be accurately determined from 1D 
ROESY experiments, with signal overlap from H-19 and H-1b meaning that NOE 
correlations observed could not be definitively attributed to H-14.  Given the NOE 
correlations observed, the fusion of the rings and the side chain stereochemistry, 
position C-14 was assigned axial on the bottom face.  This assignment was consistent 
with the well known stereochemistry of a standard cholesterol structure.  This was 
further reaffirmed by the shifts of protons around the five-membered ring system 
which are comparable to the shifts of a trans-fused ring D system.122  While the 
complete relative stereochemistry could not be unequivocally assigned on the basis of 
NMR correlations alone, the portions that were fully established are consistent with 
the common steroid configuration.  The contentious stereochemical assignments and 
remaining unassigned centres showed strong chemical shift similarities to known 
planar steroid structures and it was therefore strongly suggested that raspailoside A 
(135) contained a conventional planar steroid configuration as drawn in Figure 3.22. 
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Raspailoside A 
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Table 3.3 13C (150 MHz) and 1H (600 MHz) NMR data (CD3OD) for the oligosaccharide chain of raspailoside A (135). 
 
 
 
 
 
 
 
* (w) indicates weak signals 
 
 
 
   
13
C 
   
1
H 
 
COSY HMBC 
 
1D TOCSY 1D ROESY 
 
Position δ (ppm) mult 
1
JCH (Hz)  
δ (ppm) mult J (Hz) (
1
H-
1
H) (
1
H to 
13
C) 
   
 
Xyl-1 
            
 
(1→C-3) 
            
 
1 102.0 CH 161.0 
 
4.47 d 6.2 2 Aglycon-3, 5 
 
2, 3, 4, 5a, 5b 
2, 3, Aglycon-3, 
5b 
 
2 73.2 CH 145.9 
 
3.39 t 6.8 1, 3 1, 3 
   
S1 3 79.4 CH 147.0 
 
3.78 t 7.7 2, 4 S2-1, 2, 4 
 
1, 2, 4, 5a, 5b 1, S2-1, 2 
 
4 74.9 CH 147.2 
 
3.86 m 
 
3, 5a, 5b S3-1 
   
 
5a 62.4 CH2 147.9 
 
3.98 dd 12.0, 4.3 4, 5b 1, 3 
 
1, 2, 3, 4, 5b S3-1, 4, 5b 
 
5b 
 
CH2 145.5  
3.30 dd 12.0, 8.5 4, 5a 1 
   
 
Xyl-2 
            
 
(1→3-Xyl-1 
            
 
1 103.5 CH 159.0 
 
4.81 d 6.1 2 S1-3, 5 
 
2, 3, 4, 5a, 5b 2, 3, S1-3, 5b 
 
2 73.5 CH 146.2 
 
3.36 t 6.8 1, 3 1 (w)*, 3 (w) 
   
S2 3 75.1 CH 146.3 
 
3.45 t 7.5 2, 4 2, 4 
   
 
4 70.6 CH 140.6 
 
3.53 m 
 
3, 5a, 5b 
    
 
5a 65.5 CH2 147.5  
4.09 dd 11.8, 4.5 4, 5b 1, 3 
 
1, 2, 3, 4, 5b 1, 4, 5b 
 
5b 
 
CH2 145.1  
3.34 dd 12.0, 8.2 4, 5a 1 
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Table 3.3 – continued from previous page 
 
 
 
 
* (w) indicates weak signals 
 
   
13
C 
   
1
H 
 
COSY HMBC 
 
1D TOCSY 1D ROESY 
 
Position δ (ppm) mult 
1
JCH (Hz)  
δ (ppm) mult J (Hz) (
1
H-
1
H) (
1
H to 
13
C) 
   
 
2-NHAc-Glc-1 
            
 
(1→4-Xyl-1) 
            
 
1 100.0 CH 160.3 
 
4.63 d 7.8 2 S1-4 
 
2, 3, 4, 5, 
6a, 6b 
2(w)*, 3 (w) , S1-4 , 
S1-5a (w) 
 
2 56.1 CH 141.8 
 
3.71 t 9.5 1, 3 1, 2', 3 
   
 
2' 174.2 C 
          
 
2'' 22.8 CH3 127.8  
1.98 s 
  
2' 
   
S3 3 84.5 CH 144.4 
 
3.67 t 9.2 2, 4 S4-1, 2, 4, 5 
   
 
4 69.8 CH 145.8 
 
3.45 t 8.9 3, 5 3 (w), 5 
   
 
5 77.4 CH 
  
3.32 m 
 
4, 6a, 6b 6 (w) 
   
 
6a 62.1 CH2 141.9  
3.87 dd 11.7, 2.1 5, 6b 4 
   
 
6b 
 
CH2 142.0 
 
3.71 
  
5, 6a 5 
   
 
Glc-2 
            
 
(1→3-GlcNHAc) 
            
 
1 104.7 CH 160.1 
 
4.32 d 7.8 2 2, 3, S3-3 
 
2, 3, 4, 5, 
6a, 6b 
2, S3-2 , 3, S3-3, 5 
 
2 74.5 CH 144.5 
 
3.22 t 8.5 1, 3 1, 3 
   
S4 3 77.4 CH 
  
3.34 t 8.6 2 
    
 
4 71.1 CH 144.8 
 
3.29 
   
5 
   
 
5 77.9 CH 142.2 
 
3.30 
       
 
6a 62.2 CH2 141.9 
 
3.87 dd 11.9, 1.9 6b 
    
 
6b 
 
CH2 140.7  
3.63 dd 11.9, 5.9 6a 
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Table 3.4 13C (150 MHz) and 1H (600 MHz) NMR data (CD3OD) for the aglycon moiety of Raspailoside A (135). 
 
 
 
 
* (w) indicates weak signals 
 
13
C 
 
1
H 
 
COSY HMBC 
 
1D TOCSY 1D ROESY 
Position δ (ppm) mult 
 
δ (ppm) 
 
(
1
H-
1
H) (
1
H to 
13
C) 
   
1a 38.3 CH2  
1.88 
 
1b, 2a, 2b 2, 5, 10, 19 
   
1b 
 
CH2  
1.07 
 
1a, 2a, 2b 2, 9, 10 
  
2b, 3 (w), 9 
2a 30.5 CH2  
1.87 
 
1a, 1b, 2b 3 5, 10 
   
2b 
 
CH2  
1.60 
 
1a, 1b, 2a, 3 
    
3 79.6 CH 
 
3.49 
 
2a, 2b, 4a, 4b 
  
1a, 1b, 2a, 2b, 4a, 4b S1-1, 1b, 2a, 4a, 
4a 39.3 CH2  
2.40 
 
3, 4b 2, 3, 5, 6, 10 
 
1a, 1b, 2a, 2b, 3, 4b, 6, 9 S1-1, 3, 4b, 6 
4b 
 
CH2  
2.24 
 
3, 4a 
  
1a, 1b, 2a, 2b, 3, 4a, 6 2b (w), 4a, 19 
5 141.4 C 
        
6 122.5 CH 
 
5.38 
 
7a, 7b (w)* 4, 8, 10 
 
7a, 7b, 8, 9 (w), 14 (w) 4a, 7a, 7b (w) 
7a 32.7 CH2  
1.99 
 
6, 7b, 8 6 
 
6, 8, 9, 14 6, 7b, 8 
7b 
 
CH2  
1.53 
 
6, 7a, 8 (w) 5, 6, 8 
   
8 32.9 CH 
 
1.49 
 
7a, 9, 14 7, 9, 10, 14 
   
9 51.4 CH 
 
0.95 
 
8, 11 8, 11, 12, 19 
 
6, 7a, 7b, 8, 11a, 11b, 12a, 12b, 14, 
15a, 15b, 16a, 16b, 17, 20, 22a, 22b, 
23a, 23b 
1b, 11b, 12b (all w) 
10 37.5 C 
        
11a 21.8 CH2 
 
1.54 
 
9, 11a, 11b 8, 9, 12, 13 
   
11b 
 
CH2  
1.54 
 
9, 11a, 11a 8, 9, 12, 13 
   
12a 40.8 CH2 
 
2.04 
 
11a, 11b, 12b 9, 11, 13, 14 
   
12b 
 
CH2  
1.20 
 
11a, 11b, 12a 11, 13, 17, 18 
   
13 43.2 C 
        
14 57.8 CH 
 
1.04 
 
8, 15a, 15b 8, 13, 15 , 18 
  
7b, 11b, 15a 
…. …. …. 
 
…. 
 
…. …. 
 
…. …. 
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Table 3.4 – continued from previous page 
   
 
* (w) indicates weak signal 
Notes: Protons H-9 and H-21 overlapped and as they were part of a continuous protonated carbon chain therefore all signals seen in the spectra were recorded for both protons.  
Overlap was observed in the 1D ROESY spectra between H-9 and H-21 and also H-1b, H-14 and H-19, which were separated by 0.4 ppm, which made NOE determination difficult.
 
13
C 
 
1
H 
 
COSY HMBC 
 
1D TOCSY 1D ROESY 
Position δ (ppm) mult 
 
δ (ppm) 
 
(
1
H-
1
H) (
1
H to 
13
C) 
   
15a 25.0 CH2  
1.63 
 
14, 15b, 16a, 
16b 
13, 14 (w)* 
   
15b 
 
CH2 
 
1.12 
 
14, 15a, 16a, 
16b 
8, 13, 14, 16 
   
16b 
 
CH2  
1.34 
 
15a, 15b, 16a, 
17     
17 57.1 CH 
 
1.13 
 
16a, 16b, 20 
12, 13, 16, 18, 
20, 21, 22    
18 12.0 CH3  
0.72 
  
12, 13, 14, 17 
  
12a (w), 14, 17, 20, 21 
19 19.5 CH3  
1.03 
  
1, 5, 9, 10 
  
1a, 4b, 11a 
20 36.4 CH 
 
1.42 
 
17, 21, 22b 
    
21 18.7 CH3 
 
0.95 
 
20 17, 20, 22 
 
6, 7a, 7b, 8, 11a, 11b, 12a, 12b, 14, 
15a, 15b, 16a, 16b, 17, 20, 22a, 22b, 
23a, 23b 
12a, 20, 23a, 23b 
22a 30.7 CH2  
1.73 
 
22b, 23a, 23b 20, 21, 23, 24 
   
22b 
 
CH2 
 
1.23 
 
22a, 23a, 23b 20, 21, 23, 24 
   
23a 38.0 CH2  
2.54 
 
22a, 22b, 23b 20, 22, 24 
 
17 (w), 20, 21, 22a, 22b, 23b 21 
23b 
 
CH2 
 
2.46 
 
22a, 22b, 23a 20, 22, 24 
   
24 217.9 C 
        
25 41.6 CH 
 
2.68 
 
26, 27 24 (w), 26, 27 
 
26, 27 26, 27 
26 18.4 CH3  
1.07 
 
27 24, 25, 27 
  
25 
27 18.4 CH3 
 
1.07 
 
26 24, 25, 26 
  
25 
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3.6. Steroidal Glycosides from Sponges 
Steroidal glycosides are a wide spread class of natural products that have been 
prevalent in terrestrial and marine sources.  Initially, steroid glycosides were 
considered to be typical metabolites of higher plants and it was not until the 1960s 
that they were isolated from echinoderms.  It was then, not until the 1980s that this 
class of natural product was reported from marine sponges.   
The term steroidal glycoside has been used to classify both steroidal glycosides with a 
cholesterol-like aglycon and triterpene glycosides which differ with the presence of a 
gem-dimethyl group at C-4 of the aglycon (lanosterol aglycon framework).  Numerous 
triterpene glycosides have been reported from marine sponges since the 1980s, 
however, there have been fewer steroidal glycosides (cholesterol aglycon framework) 
isolated over the same time frame. 
The first compounds isolated from a marine sponge under the class steroidal 
glycosides were the sarasinosides A1, B1 and C1 (136-138), isolated from the Palauan 
sponge Asteropus sarasinosum.123-124  The sarasinosides were revealed to contain a 
lanosterol-like aglycon with the characteristic gem-dimethyl at C-4.  In separate 
studies, the sarasinosides isolated only showed mild micromolar cytotoxicity towards 
lymphocytic leukaemia.123-124  
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The first steroidal glycoside that showed demethylation at C-4 was eryloside A (139) 
which was reported from the Red Sea sponge Erylus lendenfeldi in 1989.125  Eryloside A 
was revealed to have mild micromolar anti-tumor and antifungal activity.125  The 
compounds pachastrelloside A (140), reported from the Japanese sponge Pachastrella 
in 1990, and wondosterols A-C (141-143), isolated from a two sponge association in 
Korea in 1999, observed complete demethylation at C-4, replaced by a glycosidic 
linkage.126-127  Most steroidal glycosides contain a single glycosidic linkage at C-3, 
however, 140-143 observed a glycosidic linkage at C-4 while 140 observed a second 
glycosidic linkage at C-7.  Pachastrelloside A was found to have mild micromolar 
inhibition against cell division of fertilised starfish eggs while wondosterols A-C 
exhibited micromolar cytotoxicity towards murine leukaemia cells.126-127  Wondosterols 
A and C also showed mild anti-bacterial activity against Pseudomonas aeruginosa and 
Escherichia coli.127  This indicated that multiple glycosidic linkages off the aglycon did 
not necessarily enhance the biological activity of a steroidal glycoside. 
 
More recently, pandarosides A-M (144-156) and their methyl esters (157-168) have 
been reported from the Caribbean sponge Pandorus acanthifolium.128-130  The 
pandarosides contain a common glycosidic linkage at C-3 and are among the first 
marine sponge steroidal glycosides recorded to contain a C-4 methylene.  The 
pandarosides and their methyl esters showed antiprotozoal activity in the micromolar 
range. 
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144  R1 = Et,   R2 = β-Glc,   R3 = H 
145  R1 = Et,   R2 = H,          R3 = H 
146  R1 = H,    R2 = β-Glc,   R3 = H 
147  R1 = H,    R2 = H,         R3 = H 
154  R1 = Me, R2 = β-Glc,   R3 = H 
157  R1 = Et,   R2 = β-Glc,   R3 = Me 
158  R1 = H,    R2 = β-Glc,   R3 = Me 
159  R1 = H,    R2 = H,         R3 = Me 
166  R1 = Me, R2 = β-Glc,   R3 = Me 
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3.7. Biological Activity 
The biological activity of raspailoside A was investigated by researchers in the School 
of Biological Sciences, VUW.  A sample was submitted to the chemical genetics 
program whereby it was tested for high-level inhibition (100 μM) against two haploid 
yeast strains of Saccharomyces cerevisiae, a wild type and a drug-sensitive mutant 
(Δpdr).  In the yeast, a complex pleiotropic drug resistance (PDR) network of 
membrane-bound pumps is responsible for ejecting xenobiotics before they can reach 
inhibitory levels within the cell.  The PDR network is controlled by the transcription 
factor genes pdr1 and pdr3.  Deletion of pdr1 and pdr3 produces a viable double-
deletion mutant strain, which is sensitised to most xenobiotics in comparison to the 
wild type.  The drug-sensitive mutant is typically 30-fold more susceptible than the 
wild type, however, as not all xenobiotics are substrates for the PDR network testing in 
the drug-sensitive mutant strain will not necessarily improve the IC50 value.
131  
Bioassay results of raspailoside A showed inactivity in either strain at 100 μM.  This 
suggested that either it is not a PDR substrate or, that a higher dose (not performed) 
was needed to achieve activity in the assay.   Raspailoside A was also subjected to an 
MTT assay against a human promyelocytic leukaemia cell line.  Concentrations ranging 
from 0.01 μM to 50 μM were used in this study, however, the compound displayed no 
activity at any concentration. 
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3.8. Summary 
Steroidal glycoside metabolite isolation is frequently reported from the marine 
environment, through echinoderms, in particular starfish and sea cucumbers, which 
are well known to produce a wide variety of steroidal glycosides.  However, there have 
been very few reports of these metabolites being isolated from sponge specimens.  
Initial studies of PTN2_45D were conducted looking at the isolation of novel 
clerodanes, however, the early identification of anomeric sugar protons and non-lipid 
aglycon functionality, in the screening of PTN2_45D prompted further purification and 
eventual isolation of raspailoside A.  A variety of NMR experiments were used to 
elucidate the full structure and assigned relative stereochemistry.  Raspailoside A was 
found to exhibit limited biological activity in the HL-60 and yeast assays to which it was 
subjected. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 89 
 
Chapter 4  
 
Conclusion 
Over the course of this study, 11 Tongan marine algae and one New Zealand sponge 
were investigated for the presence of novel secondary metabolites.  One novel 
compound was isolated from the sponge, however, the algae specimens studied were 
found to only contain known compounds.  Utilisation of the updated in-house HMBC 
screening protocol, along with a number of modern NMR techniques, facilitated 
partial, if not full structural elucidation of these compounds. 
A previous study of New Zealand red algae found a large number of novel and diverse 
secondary metabolites however this study of red, green and brown Tongan algae was 
unable to yield any such structural novelty or diversity across the samples.  Many of 
the species showed the strong presence of the isolated and semi-purified primary 
metabolite 76, while the brown algae specimens showed the presence substructure 
83, previously reported in known fulvellic acid analogues.  In each case full elucidation 
of the fatty acid chains was not performed due to a lack of novelty and inconclusive 
mass spectrometry results.  During this study fistularin-3 (86) was unintentionally 
elucidated through the presence of a sponge impurity during extraction.   
The results of this study suggested that the opposite effect was seen in algae 
compared to sponges in terms of the concentrations and structural diversity of 
secondary metabolites from temperate and tropical sources.  The strong presence of 
the primary metabolite 76 in tropical algae, compared to the temperate New Zealand 
algae studied indicates that the compound might play a role in the algae that is 
affected by external conditions.  Fistularin-3 was isolated from a small sponge 
contaminant in an algal extraction.  Subsequent re-extraction of a clean sample of the 
same algae exhibited no such resonances.  This discovery reaffirmed the idea that 
tropical algae produce far less secondary metabolites than tropical sponges.  This may 
suggest that environmental factors in tropical regions have an effect on secondary 
metabolite production in marine macro-algae.  Although the algae sample size was 
relatively small, the information that this study garnered provided an interesting 
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comparison between tropical and temperate algae and sponges.  The study suggested 
that even though current and future studies of marine sponges have made their way to 
the more diverse tropical environment, the study of algae in future may be better 
conducted in the temperate environment.    
The isolation of a novel steroidal glycoside from a Raspailia sponge specimen 
previously deemed ‘uninteresting’, morphologically and when analysed using the HSQC 
screening protocol, indirectly proved the validity of the HMBC screening protocol.  
Raspailoside A (135) proved difficult to isolate and purify with several different 
procedures utilised in an effort to separate it from a very similar minor compound.  
Structural elucidation presented many challenges that required the use of less 
common experiments, including the HSQC-TOCSY.  The biological activity of 135 was 
studied across HL-60 and yeast assays, with limited activity observed.  Since the 1980s, 
reported instances of the isolation of steroidal glycosides from marine sponges have 
primarily been triterpene glycosides.  Over the same period, there have been very few 
reported instances of steroidal glycosides isolated from marine sponges that contained 
the lanosterol-like aglycon moiety present in raspailoside A. 
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Chapter 5  
 
Experimental 
5.1. General 
All NMR spectra collected, were recorded using a Varian DirectDrive 600 (operating at 
600 MHz for 1H nuclei and 150 MHz for 13C nuclei) spectrometer.  The NMR instrument 
was equipped with an inverse-detected triple resonance HCN cryogenic probe 
operating at 25 K.  The chemical shifts observed δ (ppm) were referenced to the 
residual solvent peak.132  Mass spectrometry data was collected using an Agilent 6530 
Q/TOF lcms (liquid chromatography-mass spectrometry) instrument.     
Thin layer chromatography (TLC) analysis was performed using Macherey-Nagel plastic 
Polygram SIL G/UV254 plates.  The TLC plates were visualised under UV light (λ = 254 
nm) then dipped in a 0.1% vanillin/EtOH solution followed by a 5% conc H2SO4/MeOH 
solution then heated to visualise spots.  Reversed-phase chromatography on PSDVB 
was performed using Supelco Diaion HP20 and HP20ss.  Normal-phase 
chromatography was performed using 2,3-dihydroxypropoxy-propyl-derivatised silica 
(DIOL), from YMC Co. Ltd.  Size exclusion column chromatography was also performed, 
utilising Sigma Aldrich Sephadex LH20.  The solvents used in normal- and reversed-
phase column chromatography were of HPLC or analytical grade quality.  All other 
solvents were purified by distillation before use.  Solvent mixtures are reported as 
%vol/vol unless otherwise stated.  High-performance liquid chromatography (HPLC) 
was performed using a Rainin Dynamax SD-200 solvent delivery system with 25 mL 
pump heads.  The system was equipped with a Varian ProStar 335 photodiode array 
detector, for UV/vis detection.  All HPLC was performed using a reversed-phase C18 
column support (both in analytical and semi-prep column sizes) with solvents of HPLC 
grade with additional purification using a Millipore filtration system. 
The algae screened were collected from different locations around the islands of 
Vava’u and Tongatapu, Kingdom of Tonga, between the 19/11/2009 and 27/11/2009.  
The unknown sponge species of the genus Raspailia that was analysed in this study 
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was collected by SCUBA from Elizabeth Reef, Tutukaka, New Zealand on 23/4/2003.  
All samples were frozen upon collection and stored in freezers at -20 ᵒC until required. 
 
5.2. Isolation of Algal Natural Products 
Sample PTN4_17G 
The green algae PTN4_17G (39 g wet weight, Houma blowholes, Tongatapu) was twice 
extracted over 24 h in 350 mL of MeOH.  The filtered second and first extracts were 
passed through a 40 mL column of HP20 beads.  The resulting eluent was diluted with 
700 mL of distilled H2O (now a 50% MeOH in H2O solution) and passed back through 
the HP20 column.  The eluent was diluted again with 1.4 L of distilled H2O (now a 25% 
MeOH in H2O solution) with the resulting 2.8 L eluent passed back through the column.  
The column was then eluted with 120 mL of distilled H2O followed by sequential 120 
mL portions of 30%, and 70% Me2CO in H2O and 100% Me2CO.  The 70% Me2CO in H2O 
fraction was backloaded onto a 10 mL HP20 column, diluted to 25%, and then eluted 
with 120 mL of Me2CO.  The Me2CO eluent was concentrated under reduced pressure. 
The resulting dry material was sub-sampled and put through a secondary protocol 
using a 2 mL column of HP20ss.  The sample was loaded onto the column and then 
eluted sequentially with 6 mL fractions of solvent.  The elutions were 40%, 50%, 60%, 
70%, 80% and 90% MeOH in H2O (fractions a-f) and 100% MeOH (fractions g-i).  
Fractions g-i were combined and passed through a normal-phase 1 cm DIOL column, 
eluting with 5 mL volumes of CH2Cl2, 10%, 25%, 50%, and 75% EtOAc in CH2Cl2, EtOAc, 
MeOH and finally Me2CO (fractions a-g, 50% and 75% were collected in the same 
fraction d).  Full NMR spectral data of fraction f revealed the avrainvilloside 
substructure 76 (2.4 mg). 
Sample BJN1_92Ff 
White powder; NMR data see Table 2.2 (CD3OD); [α]
    
 
 +13.6o (EtOH, c=0.147). 
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Sample PTN4_18E 
The brown algae PTN4_18E (24 g wet weight, collected from Houma blowholes, 
Tongatapu) was twice extracted over 24 h in 200 mL of MeOH.  The filtered second and 
first extracts were passed through a 20 mL column of HP20 beads.  The resulting 
eluent was diluted with 400 mL of distilled H2O (now a 50% MeOH in H2O solution) and 
passed back through the HP20 column.  The eluent was diluted again with 800 mL of 
distilled H2O (now a 25% MeOH in H2O solution) with the resulting 1.6 L eluent passed 
back through the column.  The column was then eluted with 60 mL of distilled H2O 
followed by sequential 60 mL portions of 30%, and 75% Me2CO in H2O and 100% 
Me2CO.  The 75% Me2CO in H2O fraction was backloaded onto a 10 mL HP20 column, 
diluted to 25%, and then eluted with 100 mL of Me2CO.  The Me2CO eluent was 
concentrated under reduced pressure. 
The dry sample was then dissolved in a minimum of CH2Cl2, loaded onto a 10 mL DIOL 
column and eluted with 60 mL volumes of CH2Cl2, 10%, and 50% EtOAc in CH2Cl2, 
EtOAc, 50% MeOH in EtOAc and MeOH (fractions a-f).  Fraction a was concentrated 
under reduced pressure and re-dissolved in 10% CH2Cl2 in hexanes.  The sample was 
loaded onto a 2 mL DIOL column and eluted with 10 mL volumes of hexanes, 25%, 
50%, and 75% CH2Cl2 in hexanes, CH2Cl2 and MeOH (fractions 1-6).  Full NMR spectral 
data of fraction 3 revealed substructure 83 (2.9 mg). 
Sample BJN2_35Fb3 
White powder; NMR data see Table 2.3 (CD3OD); [α]
    
 
 +23.0o (EtOH, c=0.187). 
 
Sample PTN3_38C 
The red algae PTN3_38C (25 g wet weight, collected from Split rock, Vava’u) was twice 
extracted over 24 h in 200 mL of MeOH.  The filtered second and first extracts were 
passed through a 20 mL column of HP20 beads.  The resulting eluent was diluted with 
400 mL of distilled H2O (now a 50% MeOH in H2O solution) and passed back through 
the HP20 column.  The eluent was diluted again with 800 mL of distilled H2O (now a 
25% MeOH in H2O solution) with the resulting 1.6 L eluent passed back through the 
column.  The column was then eluted with 60 mL of distilled H2O followed by 
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sequential 60 mL portions of 30%, and 75% Me2CO in H2O and 100% Me2CO.  A further 
two 60 mL Me2CO elutions were performed to strip the column of the crude sample.  
The 75% Me2CO in H2O fraction was backloaded onto a 10 mL HP20 column, diluted to 
25%, and then eluted with 100 mL of Me2CO.  The Me2CO eluent was concentrated 
under reduced pressure. 
The 75% Me2CO sample was dissolved in 10% MeOH in CH2Cl2, loaded onto a 10 mL 
DIOL column, and subsequently eluted with 60 mL volumes of CH2Cl2, 10%, and 50% 
EtOAc in CH2Cl2, EtOAc, 50% MeOH in EtOAc, MeOH and 50% H2O in MeOH (fractions 
1-7).  Fraction 3 was concentrated under reduced pressure and the resulting NMR full 
data set showed the presence of the known compound fistularin-3 (86, 10.4 mg). 
Sample BJN2_37Hb3 
Colourless solid; NMR data see Table 2.4; HRESIMS observed m/z 1130.6895 [M+Na]+, 
C31H30O11N4Br6Na
+ requires 1130.6909, Δ -1.2 ppm; [α]    
 
 +93.9o (EtOH, c=0.713). 
 
 
 
 
 
 
 
 
 
 
 
 95 
 
5.3. Isolation of Natural Products from Raspailia sp. 
The Raspailia sponge species PTN2_45D (107.7 g wet weight, collected from Elizabeth 
reef, Tutukaka) was twice extracted over 24 h in 350 mL of MeOH.  The filtered second 
and first extracts were passed through an 80 mL column of HP20 beads.  The resulting 
eluent was diluted with 700 mL of distilled H2O (now a 50% MeOH in H2O solution) and 
passed back through the HP20 column.  The eluent was diluted again with 1.4 L of 
distilled H2O (now a 25% MeOH in H2O solution) with the resulting 2.8 L eluent passed 
back through the column.  The column was then eluted with 250 mL of distilled H2O 
followed by sequential 250 mL portions of 20%, 40%, 60%, and 80% Me2CO in H2O and 
100% Me2CO.  The column was eluted with a further 250 mL of Me2CO to strip the 
column of remaining crude sample.  The first four elutions were backloaded onto 
separate 25 mL HP20 columns, by dilution to 25%, and then eluted using 100 mL of 
Me2CO in each case.  All five samples were then concentrated under reduced pressure, 
leaving dry material. 
 
Raspailodane A (126) 
The 80% Me2CO in H2O fraction was sub-sampled (initially two separate samples) with 
one sample being purified using DIOL.  The sample was dissolved in a minimum of 
CH2Cl2, loaded onto a 10 ml DIOL column and subsequently eluted with 60 ml portions 
of CH2Cl2, 10% and 50% CH2Cl2 in EtOAc, EtOAc, 50% MeOH in EtOAc and MeOH 
(fractions a-f).  Analysis of fraction a, led to the elucidation of the known clerodane 
raspailodane A (126, 10.7mg). 
Sample BJN3_56Ba 
Pale yellow solid; HRESIMS observed m/z 315.1946 [M+H]+, C20H27O3 requires 
315.1955, Δ -2.92 ppm; [α]    
 
 +32.0o (EtOH, c=0.707); NMR data consistent with 
West’s data.36 
 
 
 
 96 
 
Raspailoside A  
The 60% Me2CO in H2O fraction was sub-sampled, with one sample dissolved in 50% 
MeOH in CH2Cl2 and loaded onto an LH20 column (prepared in 50% MeOH in CH2Cl2).  
The column was run in 50% MeOH in CH2Cl2, at approximately one drop per 20 s, with 
fractions collecting for 1370 s, until 78 tubes had been collected.  Tubes 25-33 were 
found to contain the compound of interest and were combined and concentrated 
under reduced pressure (sample A).  A second LH20 column was run on the remaining 
sub-sample using the same conditions, flow rate and fraction collection time.  Seventy 
one fractions were collected with the fractions 38-59 combined and concentrated 
under reduced pressure (sample B). 
The second 80% Me2CO in H2O sample was further sub-sampled (two separate 
samples) with both samples chromatogrammed on separate LH20 columns.  The first 
sample was dissolved in 66% MeOH in CH2Cl2 and loaded onto an LH20 column 
prepared in 50%  MeOH in CH2Cl2.  The column was run in 50% MeOH in CH2Cl2 at a 
flow rate of approximately one drop per six seconds with each fraction collecting for 
600 s.  Eighty two fractions were collected with fractions 38-50, 51, 52-56 and 57-64 
collected and concentrated under reduced pressure separately (samples C-F).  The 
second sample was put through an LH20 column utilising the same parameters as the 
first sub-sample (of the original 80% Me2CO in H2O sample) with 71 fractions collected, 
of which fractions 33-43 were combined and concentrated under reduced pressure 
(sample G). 
The seven samples (A-G), collected from the four LH20 columns run across the two 
original 60% and 80% Me2CO in H2O samples, were dissolved in 50% MeOH in CH2Cl2, 
combined and loaded onto another LH20 column and run in a mobile phase of 50% 
MeOH in CH2Cl2.  The column was run at a flow rate of approximately one drop per 15 
seconds with each fraction being collected for 1380 s.  Fractions 34-39 of a total 70 
were combined and concentrated under reduced pressure.   
The concentrated sample was dissolved in 1:1:1 MeOH:EtOAc:CH2Cl2, loaded onto a 10 
mL DIOL column and eluted sequentially with 60 mL volumes of 50% EtOAc in CH2Cl2, 
EtOAc, 10%, and 25% MeOH in EtOAc and MeOH (fractions 1-6).  Fraction 5 was 
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concentrated under reduced pressure and sub-sampled (fraction 5a (11.9 mg), fraction 
5b (5.3 mg)). 
 
HPLC Purification 
Fraction 5a was chromatographed on a semi-preparative C18 reversed-phase HPLC 
column, with 80% MeOH in H2O as the mobile phase, at a flow rate of 5 mL/min.  The 
compound of interest had a retention time of approximately 1560 s and was the fourth 
fraction collected.  A full NMR data set revealed purification of the aglycon, from the 
compound of interest.  The fraction was dissolved in a 2:2:1 hexanes:DCM:MeOH 
solvent system and loaded onto an LH20 column, utilising the same running solvent as 
what it was dissolved in.  The column had a flow rate of approximately 7 seconds per 
drop and each fraction was collected for 1380 s.  No further purification was observed 
with a mass of 2.3 mg recovered. 
Sample BJN3_84Fe4 
White solid; NMR data consistent with Tables 4.1 and 4.2. 
 
 
LH20 Purification 
Fraction 5b (centrifuged off as a solid) was purified using predominantly LH20 columns 
with different mobile phases.  The sample was dissolved in a minimum of 50% MeOH 
in CH2Cl2, using a centrifuge to separate off any remaining un-dissolved sample, and 
then loaded onto an LH20 column and run in 50% MeOH in CH2Cl2.  The column was 
run at a flow rate of approximately one drop per 10 seconds with each fraction 
collecting for 1380 s, until 62 total fractions had been collected.  Fractions 45-53 were 
combined, concentrated under reduced pressure and then re-dissolved in 20% MeOH 
in CH2Cl2 and loaded back onto the LH20 column containing a 20% MeOH in CH2Cl2 
running solvent.  Seventy seven total fractions were collected off the column at a flow 
rate of approximately one drop per 10 seconds with each fraction collected for 1380 s.  
Fractions 61-67, 68-71 and 73-77 were collected separately.  A MeOH strip of the LH20 
column was performed to ensure no sample remained on the column.   
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Fractions 68-71 were concentrated under reduced pressure and re-dissolved, together 
with the remaining un-dissolved solid in a solvent system of 20% MeOH in CH2Cl2, and 
loaded onto the column.  The column was run with a 20% MeOH in CH2Cl2 mobile 
phase at a flow rate of one drop per 10 seconds with each fraction collected for 1380 s.  
A total of 133 fractions were collected with fractions 83-123 combined and 
concentrated under reduced pressure.  Again, the LH20 column was stripped using 
MeOH, with the collected eluent combined with the previous column strip and 
concentrated under reduced pressure.  Fractions 83-123 and the column strips were 
dissolved in 2:2:1 hexanes:CH2Cl2:MeOH and loaded onto an LH20 column, with the 
mobile phase being the same 2:2:1 hexanes:CH2Cl2:MeOH solvent system.  The column 
was run at a flow rate of approximately six seconds per drop with each fraction 
collecting for 1380 s until 90 fractions were collected.  Fractions 50-72 were combined 
and concentrated under reduced pressure. 
The concentrated fraction 50-72 was dissolved in a 20% MeOH in EtOAc solution and 
loaded onto a 5 mL DIOL column.  The column was run isocratically in the same 20% 
MeOH in EtOAc solution with a flow rate of six seconds per drop with approximately 
two mL per fraction collected.  Fifty-five fractions were collected with the final five 
fractions being collected using 100% MeOH as the solvent.  Fractions 6 and 7 were 
combined, concentrated under reduced pressure and submitted for a full data set. 
Sample BJN4_8Fb 
White solid; NMR data see Tables 4.1 and 4.2; HRESIMS observed m/z 1029.5499 
[M+H]+, C51H83NO20 requires 1029.5508, Δ -0.91 ppm; [α]
    
 
 +42.9o (EtOH, c=0.023). 
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Appendix A 
 
Sponge Screening and Cyclic Loading Protocol 
Cyclic Loading and Backloading Process 
The process of cyclic loading (shown schematically on page 100) avoids the need to 
pre-concentrate the extract allowing the crude sample to be loaded immediately onto 
a PSDVB column.  The method follows an iterative dilution phase where the eluent is 
passed through the column, diluted with water, and then passed through the column 
again.  Under most circumstances, dilution of a crude extract with water (a polar 
solvent) would result in the precipitation of non-polar compounds.  This is avoided 
with cyclic loading since the first pass through the column removes the non-polar 
compounds in the crude extract and therefore, they will not be present in the eluent 
when it is diluted.  Further dilution with water increases the polarity of the eluent and 
leads to the slightly more polar compounds having a greater affinity for the stationary 
phase, therefore forcing their adsorption onto the stationary phase.  Subsequent runs 
through the reversed-phase column are performed to remove all the polar compounds 
from the diluted crude extract.  This process is typically run until a four-fold dilution of 
the original solvent is achieved. 
Once the cyclic loading process is completed, the next step involves elution of the 
column, which is carried out in a stepped system of increasing organic solvent 
(normally methanol or acetone) in water.  The resulting fractions collected from the 
cyclic loading procedure will contain varying amounts of water which is problematic, if 
the fraction needs to be concentrated under reduced pressure, as ‘bumping’ of organic 
solvent/water mixtures can occur under vacuum.  The cyclic loading method was 
modified to account for this with the addition of a ‘backloading’ procedure.  A water 
containing fraction collected off the cyclic loading column is diluted and cyclic loaded 
onto a smaller column of PSDVB.  The column is then eluted with organic solvent 
leaving a fraction that is now largely devoid of water which makes it easier to 
concentrate under reduced pressure. 
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The cyclic loading process 
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Screening Protocol 
The protocol used to screen the algal specimens utilised the existing sponge screening 
protocol with some slight changes in the amounts used. 
Equipment needed (per screen) 
1x Screen column loaded with 20 cm3 of HP20 equilibrated in methanol 
1x Backloading column loaded with 10 cm3 of HP20 equilibrated in methanol 
Procedure 
Voucher Sample Preparation 
 Take a voucher specimen of approximately 10 g of the crude sponge material 
ensuring that both the ectoderm and the endoderm are represented. 
 Leave in the freezer for future classification. 
Extraction 
 Extract approximately 20 g of crude sponge material in approximately 200 cm3 
of methanol overnight. 
 Filter the first extract and set aside.  Re-extract the sponge material (and any 
filter paper/celite as necessary) in approximately 200 cm3 of methanol 
overnight. 
 Filter the second extract. 
 Keep all sponge material (and any filter paper/celite as necessary) until the 
screen is complete at which time it may be discarded. 
Cyclic Loading 
 Pass the second extract through the screen column with a flow rate of 
approximately 10 cm3/min. 
 Pass the first extract through the screen column with a flow rate of 
approximately 10 cm3/min.  Combine the eluent with that of the second 
extract. 
 Dilute the combined eluents to a 50 % vol/vol solution with distilled water.  
Pass the diluted eluents back through the screen column at a flow rate of 
approximately 10 cm3/min. 
 Dilute the eluent to a 25 % vol/vol solution with distilled water.  Pass the 
diluted eluent back through the screen column at a flow rate of approximately 
10 cm3/min. 
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 The eluent should be kept until the screen is complete at which time it may be 
discarded. 
Elution 
 Elute the screen column with 60 cm3 of distilled water at a flow rate of 
approximately 10 cm3/min.  The water eluent can be discarded immediately. 
 Elute the screen column with 60 cm3 of 30% acetone in distilled water at a flow 
rate of approximately 10 cm3/min. 
 Elute the screen column with 60 cm3 of 75% acetone in distilled water at a flow 
rate of approximately 10 cm3/min. 
 Elute the screen column with 60 cm3 of acetone at a flow rate of approximately 
10 cm3/min. 
Backloading the 75% Acetone Fraction 
 Dilute the 75% acetone fraction with 60 cm3 of distilled water.  Pass the diluted 
eluent through the backloading column at a flow rate of approximately 8 
cm3/min. 
 Dilute the eluent with 120 cm3 of distilled water.  Pass the diluted eluent back 
through the backloading column at a flow rate of approximately 8 cm3/min. 
 The eluent should be kept until the screen is complete at which time it may be 
discarded. 
 Elute the backloading column with 100 cm3 of acetone. 
Processing the 75% Fraction 
 Rotary-evaporate the acetone eluent of the backloading column to dryness and 
transfer to a pre-weighed sample vial.  Evaporate to dryness and the record 
mass. 
 Prepare an NMR sample of the sample in 500 μl of CD3OD in a 5 mm NMR tube. 
NMR Analysis of the 75% Fraction 
 Run a 1H spectrum of the sample using the standard 1H experiment with 64 
transients (ca. 4 mins) 
 Run a COSY spectrum of the sample using the standard “ScreenCOSY” 
parameter set. (ca. 20 mins) 
 Run an HSQC spectrum of the sample using the standard “ScreenHSQC” 
parameter set. (ca. 5 1/2 hrs) 
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 Run an HMBC spectrum of the sample using the standard “ScreenHSQC” 
parameter set. (ca. 5 1/2 hrs) 
Backloading the 30% Acetone Fraction 
 Dilute the 30% acetone fraction with 60 cm3 of distilled water.  Pass the diluted 
eluent through the backloading column at a flow rate of approximately 8 
cm3/min. 
 Dilute the eluent with 120 cm3 of distilled water.  Pass the diluted eluent back 
through the backloading column at a flow rate of approximately 8 cm3/min. 
 The eluent should be kept until the screen is complete at which time it may be 
discarded. 
 Elute the backloading column with 100 cm3 of acetone. 
Processing the 30% Fraction 
 Rotary-evaporate the methanol eluent of the backloading column to dryness 
and transfer to a pre-weighed sample vial.  Evaporate to dryness and the record 
mass. 
 Prepare an NMR sample of the sample in 500 μL of CD3OD in a 5 mm NMR 
tube. 
NMR Analysis of the 30% Fraction 
 Run a 1H spectrum of the sample using the standard 1H experiment with 64 
transients (ca. 4 mins) 
 Run further spectra if interesting signals are observed. 
Processing the 100% Fraction 
 Rotary-evaporate the acetone eluent of the screen column to dryness and 
transfer to a pre-weighed sample vial.  Evaporate to dryness and the record 
mass. 
 Prepare an NMR sample of the sample in 700 μL of CDCl3 in a 5 mm NMR tube. 
NMR Analysis of the 100% Fraction 
 Run a 1H spectrum of the sample using the standard 1H experiment with 64 
transients. (ca. 4 mins) 
 Run further spectra if interesting signals are observed. 
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Appendix B 
 
 
 
 
 
 
 
 
 
Algae Spectra 
(Semi-Purified Samples) 
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Avrainvilloside Substructure 
 
 
1H NMR spectrum of known avrainvilloside substructure (76) (600 MHz, CD3OD) 
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Avrainvilloside Substructure 
 
13C NMR spectrum of known avrainvilloside substructure (76) (150 MHz, CD3OD) 
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Avrainvilloside Substructure 
 
 
COSY NMR spectrum of known avrainvilloside substructure (76) (600 MHz, CD3OD) 
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Avrainvilloside Substructure 
 
 
HSQC NMR spectrum of known avrainvilloside substructure (76) (600MHz, CD3OD) 
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Avrainvilloside Substructure 
 
 
HMBC NMR spectrum of known avrainvilloside substructure (76) (600 MHz, CD3OD) 
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Methacrylic Acid Substructure 
 
 
1H NMR spectrum of known methacrylic acid substructure (83) (600 MHz, CD3OD) 
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Methacrylic Acid Substructure 
 
 
13C NMR spectrum of known methacrylic acid substructure (83) (150 MHz, CD3OD)  
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Methacrylic Acid Substructure 
 
 
COSY NMR spectrum of known methacrylic acid substructure (83) (600 MHz, CD3OD) 
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Methacrylic Acid Substructure 
 
 
HSQC spectrum of known methacrylic acid substructure (83) (CD3OD) 
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Methacrylic Acid Substructure 
 
 
HMBC spectrum of known methacrylic acid substructure (83) (CD3OD) 
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Fistularin-3 
 
 
1H NMR spectrum of known compound fistularin-3 (86) (600 MHz, CD3OD) 
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Fistularin-3 
 
 
13C NMR spectrum of known compound fistularin-3 (86) (150 MHz, CD3OD) 
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Fistularin-3 
 
 
COSY spectrum of known compound fistularin-3 (86) (600 MHz, CD3OD) 
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Fistularin-3 
 
 
HSQC spectrum of known compound fistularin-3 (86) (600 MHz, CD3OD) 
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Fistularin-3 
 
 
HMBC spectrum of known compound fistularin-3 (86) (600 MHz, CD3OD) 
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Raspailoside A (135) 
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Raspailoside A – HPLC Purification 
 
 
1H NMR spectrum of raspailoside A (135) (600 MHz, CD3OD) 
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Raspailoside A – HPLC Purification 
 
 
13C NMR spectrum of raspailoside A (135) (150 MHz, CD3OD) 
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Raspailoside A – HPLC Purification 
 
 
COSY NMR spectrum of raspailoside A (135) (600 MHz, CD3OD) 
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Raspailoside A – HPLC Purification 
 
 
HSQC NMR spectrum of raspailoside A (135) (600 MHz, CD3OD) 
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Raspailoside A – HPLC Purification 
 
 
HMBC NMR spectrum of raspailoside A (135) (600 MHz, CD3OD) 
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Raspailoside A – LH20 Purification 
 
 
1H NMR spectrum of raspailoside A (135) (600 MHz, CD3OD) 
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Raspailoside A – LH20 Purification 
 
 
DQF COSY NMR spectrum of raspailoside A (135) (600 MHz, CD3OD) 
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Raspailoside A – LH20 Purification 
 
 
HSQC NMR spectrum of raspailoside A (135) (600 MHz, CD3OD) 
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Raspailoside A – LH20 Purification 
 
 
Band-selective HSQC NMR spectrum of raspailoside A (135) (600 MHz, CD3OD)  
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Raspailoside A – LH20 Purification 
 
 
Band-selective HSQC NMR spectrum of raspailoside A (135) (600 MHz, CD3OD) 
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Raspailoside A – LH20 Purification 
 
 
HMBC NMR spectrum of raspailoside A (135) (600 MHz, CD3OD) 
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